<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000116.pub5" GROUP_ID="PREG" ID="641799080215042129" MERGED_FROM="" MODIFIED="2015-12-21 13:15:45 +0000" MODIFIED_BY="Leanne Jones" REVIEW_NO="0161" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="11.0">
<COVER_SHEET MODIFIED="2015-12-21 13:15:45 +0000" MODIFIED_BY="Leanne Jones">
<TITLE>Fetal electrocardiogram (ECG) for fetal monitoring during labour</TITLE>
<CONTACT MODIFIED="2015-12-21 13:15:45 +0000" MODIFIED_BY="Leanne Jones"><PERSON ID="7935" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>James P</FIRST_NAME><LAST_NAME>Neilson</LAST_NAME><POSITION>Professor of Obstetrics and Gynaecology</POSITION><EMAIL_1>jneilson@liverpool.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Department of Women's and Children's Health</DEPARTMENT><ORGANISATION>The University of Liverpool</ORGANISATION><ADDRESS_1>First Floor, Liverpool Women's NHS Foundation Trust</ADDRESS_1><ADDRESS_2>Crown Street</ADDRESS_2><CITY>Liverpool</CITY><ZIP>L8 7SS</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 151 7959551</PHONE_1><FAX_1>+44 151 7024024</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2015-12-21 13:15:45 +0000" MODIFIED_BY="Leanne Jones"><PERSON ID="7935" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>James P</FIRST_NAME><LAST_NAME>Neilson</LAST_NAME><POSITION>Professor of Obstetrics and Gynaecology</POSITION><EMAIL_1>jneilson@liverpool.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Department of Women's and Children's Health</DEPARTMENT><ORGANISATION>The University of Liverpool</ORGANISATION><ADDRESS_1>First Floor, Liverpool Women's NHS Foundation Trust</ADDRESS_1><ADDRESS_2>Crown Street</ADDRESS_2><CITY>Liverpool</CITY><ZIP>L8 7SS</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 151 7959551</PHONE_1><FAX_1>+44 151 7024024</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2015-11-02 15:20:53 +0000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="23" MONTH="9" YEAR="2015"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="23" MONTH="9" YEAR="2015"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="22" MONTH="9" YEAR="2017"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="1997"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="1997"/>
<LAST_CITATION_ISSUE ISSUE="12" YEAR="2015"/>
</DATES>
<WHATS_NEW MODIFIED="2015-11-30 16:24:23 +0000" MODIFIED_BY="Heather Maxwell">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-11-30 16:24:23 +0000" MODIFIED_BY="Heather Maxwell">
<DATE DAY="23" MONTH="9" YEAR="2015"/>
<DESCRIPTION>
<P>Search updated. Five new reports identified (four trials): one was included (<LINK REF="STD-Belfort-2015" TYPE="STUDY">Belfort 2015</LINK>); one was excluded (<LINK REF="STD-Ignatov-2012" TYPE="STUDY">Ignatov 2012</LINK>); one is awaiting classification (<LINK REF="STD-Gongora-2014" TYPE="STUDY">Gongora 2014</LINK>); and one is ongoing (<LINK REF="STD-Bach-2012" TYPE="STUDY">Bach 2012</LINK>). 'Risk of bias' tables completed with retrospective information.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2015-11-02 15:20:25 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="23" MONTH="9" YEAR="2015"/>
<DESCRIPTION>
<P>Conclusions remain unchanged. A 'Summary of findings' table has been incorporated. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2014-08-19 13:03:47 +0100" MODIFIED_BY="Leanne V Jones">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-08-19 13:03:44 +0100" MODIFIED_BY="Leanne V Jones">
<DATE DAY="12" MONTH="3" YEAR="2013"/>
<DESCRIPTION>
<P>Review updated. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-08-19 13:03:47 +0100" MODIFIED_BY="Leanne V Jones">
<DATE DAY="12" MONTH="2" YEAR="2013"/>
<DESCRIPTION>
<P>New search. No new trials identified but citation for a secondary analysis of data from <LINK REF="STD-Westerhuis-2010" TYPE="STUDY">Westerhuis 2010</LINK> trial added, and ongoing trial in US noted (<LINK REF="STD-Spong-2013" TYPE="STUDY">Spong 2013</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2013-03-12 14:40:53 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="28" MONTH="2" YEAR="2012"/>
<DESCRIPTION>
<P>Review updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-03-12 14:40:57 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="28" MONTH="2" YEAR="2012"/>
<DESCRIPTION>
<P>Search updated. No new trials identified. References are included to published revisions of the <LINK REF="STD-Amer_x002d_Wahlin-2001" TYPE="STUDY">Amer-Wahlin 2001</LINK> trial data. Economic analysis of the <LINK REF="STD-Westerhuis-2010" TYPE="STUDY">Westerhuis 2010</LINK> trial data cited.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-03-12 11:44:22 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="19" MONTH="5" YEAR="2011"/>
<DESCRIPTION>
<P>Search updated. New trial added (<LINK REF="STD-Westerhuis-2010" TYPE="STUDY">Westerhuis 2010</LINK>). Results of existing trial (<LINK REF="STD-Amer_x002d_Wahlin-2001" TYPE="STUDY">Amer-Wahlin 2001</LINK>) modified, with explanation. Outcome measures refined and classed as primary and secondary. Although the results are different, the overall conclusions remain unchanged.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2011-06-14 15:22:11 +0100" MODIFIED_BY="Sonja L  Henderson">
<DATE DAY="17" MONTH="4" YEAR="2009"/>
<DESCRIPTION>
<P>Search updated and two excluded studies added (<LINK REF="STD-Hruban-2006" TYPE="STUDY">Hruban 2006</LINK>; <LINK REF="STD-Janku-2006" TYPE="STUDY">Janku 2006</LINK>).</P>
<P>Unpublished data from the <LINK REF="STD-Vayssiere-2007" TYPE="STUDY">Vayssiere 2007</LINK> trial added.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2009-04-27 13:37:02 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="10" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>The search has been updated and an additional trial added (<LINK REF="STD-Vayssiere-2007" TYPE="STUDY">Vayssiere 2007</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-04-27 13:36:57 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="4" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>It came to our notice that one of the included trials was being investigated by the relevant university because of allegations of research misconduct. We have added text to the review to advise that the results of this review should be interpreted with great caution until the university investigation is completed and the conclusions publicised.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-04-27 13:36:43 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-11-11 16:59:22 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="6" MONTH="4" YEAR="2006"/>
<DESCRIPTION>
<P>Search updated. </P>
<P>Data from a newly published trial from Finland have been included. A recent publication has discussed the identification of 'protocol violations' at interim analysis mid-way through the Swedish trial; these were used to 're-train' clinical staff in the recruiting centres.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>The University of Liverpool</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2015-12-21 13:06:57 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2015-11-02 15:51:18 +0000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-09-02 15:41:57 +0100" MODIFIED_BY="Frances J Kellie">Fetal electrocardiogram (ECG) for fetal monitoring during labour</TITLE>
<SUMMARY_BODY MODIFIED="2015-11-02 15:51:18 +0000" MODIFIED_BY="[Empty name]">
<P>Monitoring the baby's heart using electrocardiography (ECG) plus cardiotocography (CTG) during labour provides some modest help for mothers and babies when continuous monitoring is needed.</P>
<P>Strong uterine contractions during labour reduce the flow of maternal blood to the placenta. The umbilical cord may also be compressed during labour, especially if the membranes are ruptured. Usually the baby has sufficient reserve to withstand this effect but some may become distressed. Electronic heart monitoring may be suggested if the doctors think the baby is not getting enough oxygen during labour. Two different methods may be used. CTG measures the baby's heart rate together with the mother's uterine contractions. An ECG measures the heart's electrical activity and the pattern of the heart beats. This involves an electrode being passed through the woman's cervix and attached to the baby's head. This review of seven randomised controlled trials, including a total of 27,403 women, found that monitoring the baby using  ECG plus CTG resulted in fewer blood samples needing to be taken from the baby's scalp, and less surgical assistance with the birth, than with CTG alone. There was no difference in the number of caesarean deliveries and little to suggest that babies were in better condition at birth. The evidence was found to be of high quality. </P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2015-12-01 12:01:27 +0000" MODIFIED_BY="Heather Maxwell">
<ABS_BACKGROUND>
<P>Hypoxaemia during labour can alter the shape of the fetal electrocardiogram (ECG) waveform, notably the relation of the PR to RR intervals, and elevation or depression of the ST segment. Technical systems have therefore been developed to monitor the fetal ECG during labour as an adjunct to continuous electronic fetal heart rate monitoring with the aim of improving fetal outcome and minimising unnecessary obstetric interference.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To compare the effects of analysis of fetal ECG waveforms during labour with alternative methods of fetal monitoring. </P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2015-12-01 12:01:21 +0000" MODIFIED_BY="Heather Maxwell">
<P>The Cochrane Pregnancy and Childbirth Group's Trials Register (latest search 23 September 2015) and reference lists of retrieved studies.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Randomised trials comparing fetal ECG waveform analysis with alternative methods of fetal monitoring during labour.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2015-11-02 15:39:03 +0000" MODIFIED_BY="[Empty name]">
<P>One review author independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy. One review author assessed the quality of the evidence using the GRADE approach.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2015-12-01 12:01:27 +0000" MODIFIED_BY="Heather Maxwell">
<P>Seven trials (27,403 women) were included: six trials of ST waveform analysis (26,446 women) and one trial of PR interval analysis (957 women). The trials were generally at low risk of bias for most domains and the quality of evidence for ST waveform analysis trials was graded moderate to high. In comparison to continuous electronic fetal heart rate monitoring alone, the use of adjunctive ST waveform analysis made no obvious difference to primary outcomes: births by caesarean section (risk ratio (RR) 1.02, 95% confidence interval (CI) 0.96 to 1.08; six trials, 26,446 women; <I>high quality evidence</I>); the number of babies with severe metabolic acidosis at birth (cord arterial pH less than 7.05 and base deficit greater than 12 mmol/L) (average RR 0.72, 95% CI 0.43 to 1.20; six trials, 25,682 babies; <I>moderate quality evidence</I>); or babies with neonatal encephalopathy (RR 0.61, 95% CI 0.30 to 1.22; six trials, 26,410 babies; <I>high quality evidence</I>). There were, however, on average fewer fetal scalp samples taken during labour (average RR 0.61, 95% CI 0.41 to 0.91; four trials, 9671 babies; <I>high quality evidence</I>) although the findings were heterogeneous and there were no data from the largest trial (from the USA). There were marginally fewer operative vaginal births (RR 0.92, 95% CI 0.86 to 0.99; six trials, 26,446 women); but no obvious difference in the number of babies with low Apgar scores at five minutes or babies requiring neonatal intubation, or babies requiring admission to the special care unit (RR 0.96, 95% CI 0.89 to 1.04, six trials, 26,410 babies; <I>high quality evidence</I>). There was little evidence that monitoring by PR interval analysis conveyed any benefit of any sort.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2015-11-11 08:49:53 +0000" MODIFIED_BY="[Empty name]">
<P>The modest benefits of fewer fetal scalp samplings during labour (in settings in which this procedure is performed) and fewer instrumental vaginal births have to be considered against the disadvantages of needing to use an internal scalp electrode, after membrane rupture, for ECG waveform recordings. We found little strong evidence that ST waveform analysis had an effect on the primary outcome measures in this systematic review. </P>
<P>There was a lack of evidence showing that PR interval analysis improved any outcomes; and a larger future trial may possibly demonstrate beneficial effects. </P>
<P>There is little information about the value of fetal ECG waveform monitoring in preterm fetuses in labour. Information about long-term development of the babies included in the trials would be valuable.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2015-12-21 13:06:57 +0000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2015-12-01 12:01:50 +0000" MODIFIED_BY="Heather Maxwell">
<CONDITION MODIFIED="2014-12-30 17:22:47 +0000" MODIFIED_BY="[Empty name]">
<P>Labour poses a potential threat to fetal wellbeing. The supply of oxygen to the fetus requires an adequate supply of maternal blood to the placenta, a properly functioning placenta to allow transfer of oxygen from maternal to fetal blood, and a patent umbilical vein in the umbilical cord to the fetus. Strong uterine contractions in labour stop the flow of maternal blood to the placenta with intermittent decreases in oxygenation. Most fetuses have sufficient metabolic reserve to withstand this effect but those with limited reserves, notably malnourished 'growth restricted' fetuses, may become distressed. The umbilical cord may also be compressed during labour, especially if the membranes are ruptured, which may also cause distress.</P>
</CONDITION>
<INTERVENTION MODIFIED="2015-12-01 12:01:50 +0000" MODIFIED_BY="Heather Maxwell">
<P>The earliest method of monitoring fetal wellbeing during labour was by using the fetal (Pinard) stethoscope intermittently to calculate the fetal heart rate. During the 1960s and 1970s, electronic systems were developed to allow monitoring of the fetal heart rate together with the mother's uterine contractions (cardiotocography (CTG)), and these have been very widely used. To monitor the heart rate, signals can be obtained from an ultrasound transducer strapped to the mother's abdomen, or from an electrode clipped into the baby's scalp. Traces of the baby's heart rate may be 'continuous' (that is, throughout labour) or intermittent. Although the mother's mobility is limited by both methods, this is obviously greater with continuous monitoring. Non-reassuring features on a CTG trace would include unusually rapid or slow rates, a flat pattern (reduced variability), and certain types of heart rate decelerations (especially 'late' or 'severe variable' decelerations). Such observations might prompt further intervention in the form of operative delivery, or additional testing of fetal condition (<I>see</I> below).</P>
<P>A systematic review of randomised trials comparing continuous electronic fetal heart rate monitoring (CTG) and intermittent auscultation (<LINK REF="REF-Alfirevic-2013" TYPE="REFERENCE">Alfirevic 2013</LINK>), showed fewer babies having neonatal convulsions after continuous monitoring (risk ratio (RR) 0.50, 95% confidence interval (CI) 0.31 to 0.80), but at the cost of increased rates of obstetric intervention in the form of caesarean section (RR 1.63, 95% CI 1.29 to 2.07) and instrumental vaginal delivery (RR 1.15, 95% CI 1.01 to 1.33). Neonatal convulsions are often, but not always, associated with hypoxic-ischaemic encephalopathy due to hypoxaemic brain damage and may be linked to subsequent neuro-developmental disability, including cerebral palsy. It should therefore be an important goal of obstetric care to avoid neonatal convulsions. However, it is also important to avoid unnecessary obstetric interventions.</P>
<P>Cardiotocographic traces may be difficult to interpret, resulting in unnecessary operative interventions, while some significant changes go unrecognised. Computerised CTG has not proved helpful during labour (<LINK REF="REF-Dawes-1994" TYPE="REFERENCE">Dawes 1994</LINK>). Adjunctive tests have therefore been developed to be used alongside CTG, in an attempt to refine assessment of fetal wellbeing with the ultimate objective of decreasing unnecessary intervention without jeopardising fetal outcome. Fetal scalp sampling for pH or lactate estimation is the best established adjunctive technique, but it is an awkward, uncomfortable procedure for the mother and involves a stab incision in the scalp of the fetus. This has limited its appeal and pre-empts its use in areas with a high prevalence of HIV infection. An additional drawback is that, by its nature, scalp sampling can only give intermittent information about fetal acid-base status.</P>
<P>To address these challenges in intrapartum fetal monitoring, technology has been developed to monitor the fetal electrocardiographic (ECG) waveform during labour. If shown helpful to either improve fetal outcome, or decrease unnecessary intervention, or both, this has the potential advantage of providing continuous information as well as being less invasive than fetal scalp sampling (although it is not non-invasive: requiring a signal obtained from an electrode embedded in the fetal scalp).</P>
</INTERVENTION>
<THEORY MODIFIED="2014-12-30 17:23:54 +0000" MODIFIED_BY="[Empty name]">
<P>The fetal ECG, like the adult ECG, displays P, QRS, and T waves corresponding to electrical events in the heart during each beat. The P wave represents atrial contraction, QRS ventricular contraction, and T ventricular repolarisation. Two parts of the fetal ECG waveform have attracted attention from researchers: PR/RR relations and the ST waveform (<LINK REF="REF-Greene-1999" TYPE="REFERENCE">Greene 1999</LINK>). Normally there is a positive correlation between the PR interval (the time between the P wave and the R component of the QRS complex) and the RR interval, such that when the heart rate increases both PR and RR intervals shorten. In sheep experiments where the fetus was made hypoxaemic, a paradoxical effect was seen, in which the PR interval shortened despite lengthening of the RR interval ('bradycardia' or slowing of the heart rate). This led to the hypothesis that measurement of PR/RR relations might help distinguish between hypoxaemic and (less worrying) non-hypoxaemic decelerations of the human fetal heart rate during labour, thus refining assessment of fetal wellbeing.</P>
<P>Repolarisation of myocardial (heart muscle) cells is very sensitive to metabolic dysfunction, and may be reflected in changes of the ST waveform. Thus, in adults with myocardial infarction or exercise-induced angina pectoris from coronary artery disease, the ST segment may be elevated. Similar findings may be seen in fetal sheep under experimental conditions of moderate to severe hypoxaemia with an elevation of the ST segment and the T wave (<LINK REF="REF-Greene-1987" TYPE="REFERENCE">Greene 1987</LINK>). This change can be expressed as a ratio of T wave height to QRS height: the T/QRS ratio. Testing of a microprocessor-based system (<LINK REF="REF-Rosen-1989" TYPE="REFERENCE">Rosen 1989</LINK>) in observational studies in humans suggested that assessment of a combination of fetal heart rate and ST waveform changes may be clinically useful (<LINK REF="REF-Rosen-1991" TYPE="REFERENCE">Rosen 1991</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2014-12-30 17:48:08 +0000" MODIFIED_BY="[Empty name]">
<P>It is important for clinical and economic reasons to establish whether or not fetal ECG waveform analysis is helpful in improving fetal outcome, or decreasing unnecessary intervention, or both.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2015-12-01 12:02:05 +0000" MODIFIED_BY="Heather Maxwell">
<P>To compare the effects of analysis of fetal electrocardiogram (ECG) waveforms during labour with alternative methods of fetal monitoring.</P>
</OBJECTIVES>
<METHODS MODIFIED="2015-12-01 12:07:46 +0000" MODIFIED_BY="Heather Maxwell">
<SELECTION_CRITERIA MODIFIED="2015-12-01 12:02:12 +0000" MODIFIED_BY="Heather Maxwell">
<CRIT_STUDIES MODIFIED="2015-12-01 12:02:12 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised controlled trials that compare analysis of any component of the fetal electrocardiogram (ECG) during labour with alternative fetal monitoring methods. Studies using quasi-random methods of allocation (for example, alternation) were not included.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2011-06-15 11:46:44 +0100" MODIFIED_BY="Denise Atherton">
<P>Pregnant women (and their fetuses) in labour, with a perceived need for continuous electronic fetal heart rate monitoring (for reasons, <I>see</I> <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table).</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2015-11-30 17:56:10 +0000" MODIFIED_BY="Heather Maxwell">
<P>Any type of fetal electrocardiographic waveform analysis, alone or in combination with another method of fetal assessment.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2015-11-30 16:50:31 +0000" MODIFIED_BY="Heather Maxwell">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2015-11-30 16:50:16 +0000" MODIFIED_BY="Heather Maxwell">
<SUBSECTION>
<HEADING LEVEL="5">Maternal</HEADING>
<OL>
<LI>Caesarean section</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Fetal</HEADING>
<OL>
<LI>Cord artery pH less than 7.05 and base deficit greater than 12 mmol/L</LI>
<LI>Neonatal encephalopathy</LI>
</OL>
</SUBSECTION>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2015-11-30 16:50:31 +0000" MODIFIED_BY="Heather Maxwell">
<SUBSECTION>
<HEADING LEVEL="5">Maternal</HEADING>
<OL>
<LI>Fetal blood sampling</LI>
<LI>Operative vaginal delivery</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Fetal</HEADING>
<OL>
<LI>Apgar score less than seven at five minutes</LI>
<LI>Neonatal intubation</LI>
<LI>Admission to neonatal special care unit</LI>
<LI>Perinatal death</LI>
<LI>Cerebral palsy</LI>
</OL>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2015-12-01 12:04:32 +0000" MODIFIED_BY="Heather Maxwell">
<P>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group.</P>
<ELECTRONIC_SEARCHES MODIFIED="2015-12-01 12:04:32 +0000" MODIFIED_BY="Heather Maxwell">
<P>The Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register was searched by the Trials Search Co-ordinator (23 September 2015).</P>
<P>For full search methods used to populate the Pregnancy and Childbirth Group Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this link to the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html">Cochrane Pregnancy and Childbirth Group</A> in <I>The Cochrane Library</I> and select the &#8216;<I>
<B>Specialized Register</B> </I>&#8217; section from the options on the left side of the screen.</P>
<P>Briefly, the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from:</P>
<OL>
<LI>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE (Ovid);</LI>
<LI>weekly searches of Embase (Ovid);</LI>
<LI>monthly searches of CINAHL (EBSCO);</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Search results are screened by two people and the full text of all relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth Group review topic (or topics), and is then added to the Register. The Trials Search Co-ordinator searches the Register for each review using this topic number rather than keywords. This results in a more specific search set which has been fully accounted for in the relevant review sections (Included, Excluded, Awaiting Classification or Ongoing).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2015-11-18 23:05:56 +0000" MODIFIED_BY="[Empty name]">
<P>The reference lists of retrieved studies were checked and no language or date restrictions were applied to the search.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2015-12-01 12:07:46 +0000" MODIFIED_BY="Heather Maxwell">
<P>For the methods used when assessing the trials identified in the previous version of this review,<I> see </I>
<LINK REF="REF-Neilson-2013" TYPE="REFERENCE">Neilson 2013</LINK>
 .</P>
<P>The following methods were used for this update.</P>
<STUDY_SELECTION MODIFIED="2013-03-12 15:04:58 +0000" MODIFIED_BY="[Empty name]">
<P>Jim Neilson (JPN) assessed for inclusion all the potential studies identified as a result of the search strategy. </P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2014-08-19 13:21:01 +0100" MODIFIED_BY="Leanne V Jones">
<P>A form was designed to extract data. For eligible studies, JPN extracted the data using the agreed form. Data were entered into Review Manager software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>) and checked for accuracy.</P>
<P>When information regarding any of the above was unclear, JPN contacted the authors of the original reports to provide further details.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2015-12-01 12:07:02 +0000" MODIFIED_BY="Heather Maxwell">
<P>The risk of bias for each study was assessed by JPN, using the criteria outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">(1) Random sequence generation (checking for possible selection bias)</HEADING>
<P>The review author describes for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups.</P>
<P>The methods were assessed as:</P>
<UL>
<LI>low risk (any truly random process, e.g. random number table; computer random number generator);</LI>
<LI>high risk (any non random process, e.g. odd or even date of birth; hospital or clinic record number);</LI>
<LI>unclear.   </LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(2) Allocation concealment (checking for possible selection bias)</HEADING>
<P>The review author describes for each included study the method used to conceal the allocation sequence to determine whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.</P>
<P>The methods were assessed as:</P>
<UL>
<LI>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);</LI>
<LI>high risk of bias (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);</LI>
<LI>unclear risk of bias.   </LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.1) Blinding of participants and personnel (checking for possible performance bias)</HEADING>
<P>The review author describes for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. Studies were considered to be at low risk of bias if they were blinded, or if it was judged that the lack of blinding could not have affected the results. Blinding was assessed separately for different outcomes or classes of outcomes.</P>
<P>The methods were assessed as:</P>
<UL>
<LI>low, high or unclear risk of bias for participants;</LI>
<LI>low, high or unclear risk of bias for personnel.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.2) Blinding of outcome assessment (checking for possible detection bias)</HEADING>
<P>The review author describes for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. Blinding was assessed separately for different outcomes or classes of outcomes.</P>
<P>The methods used to blind outcome assessment were assessed as:</P>
<UL>
<LI>low, high or unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations)</HEADING>
<P>The review author describes for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis, including whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or supplied by the trial authors, these missing data were re-included in the analyses which were undertaken. The methods were assessed as:</P>
<UL>
<LI>low risk of bias (less than 20% missing data);</LI>
<LI>high risk of bias (greater than 20% missing data);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Selective reporting bias</HEADING>
<P>The review author describes for each included study how he investigated the possibility of selective outcome reporting bias and what he found.</P>
<P>The methods were assessed as:</P>
<UL>
<LI>low risk of bias (where it is clear that all of the study&#8217;s pre-specified outcomes and all expected outcomes of interest to the review have been reported);</LI>
<LI>high risk of bias (where not all the study&#8217;s pre-specified outcomes have been reported; one or more reported primary outcomes were not pre-specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(6) Other sources of bias</HEADING>
<P>The review author describes for each included study any important concerns about other possible sources of bias.</P>
<P>The review author assessed whether each study was free of other problems that could put it at risk of bias:</P>
<UL>
<LI>low risk of other bias;</LI>
<LI>high risk of other bias;</LI>
<LI>unclear whether there was risk of other bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(7) Overall risk of bias</HEADING>
<P>The review author made explicit judgements about whether studies are at high risk of bias, according to the criteria given in the <I>Handbook</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). With reference to (1) to (6) above, he assessed the likely magnitude and direction of the bias and whether he considered it likely to impact on the findings. In future updates, the impact of the level of bias will be explored through undertaking sensitivity analyses - <I>see </I>
<LINK TAG="SENSITIVITY_ANALYSIS" TYPE="SECTION">Sensitivity analysis</LINK>. </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of the quality of the evidence using the GRADE approach</HEADING>
<P>For this update the quality of the evidence was assessed using the GRADE approach as outlined in the <A HREF="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html">GRADE handbook</A> in order to assess the quality of the body of evidence relating to the following outcomes for the main comparison, fetal ECG plus CTG versus CTG alone, relating to the ST segment.</P>
<OL>
<LI>Caesarean section</LI>
<LI>Cord artery pH less than 7.05 and base deficit greater than 12 mmol/L</LI>
<LI>Neonatal encephalopathy</LI>
<LI>Fetal blood sampling</LI>
<LI>Operative vaginal delivery</LI>
<LI>Admission to neonatal special care unit</LI>
<LI>Perinatal death</LI>
</OL>
<P>
<A HREF="http://www.guidelinedevelopment.org/">GRADEpro</A> Guideline Development Tool was used to import data from Review Manager 5.3 (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>) in order to create a &#8217;Summary of findings&#8217; table. A summary of the intervention effect and a measure of quality for each of the above outcomes was produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias.</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2013-03-25 16:47:01 +0000" MODIFIED_BY="Denise Atherton">
<SUBSECTION>
<HEADING LEVEL="4">Dichotomous data</HEADING>
<P>For dichotomous data, results are presented as summary risk ratio with 95% confidence intervals. </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Continuous data</HEADING>
<P>No data were analysed as continuous data. In future updates, if appropriate, we will use the mean difference if outcomes are measured in the same way between trials. We will use the standardised mean difference to combine trials that measure the same outcome, but use different methods.</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2015-08-06 11:13:19 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Cluster-randomised trials</HEADING>
<P>No cluster-randomised trials were identified for inclusion. In future updates, cluster-randomised trials will be included in the analyses along with individually-randomised trials. We will adjust their standard errors using the methods described in the <I>Handbook </I>using an estimate of the intracluster correlation co-efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If ICCs are used from other sources, this will be reported and sensitivity analyses will be conducted to investigate the effect of variation in the ICC. If both cluster-randomised trials and individually-randomised trials are identified, the relevant information will be synthesised. It will be considered reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely.</P>
<P>Heterogeneity in the randomisation unit will be acknowledged and a sensitivity analysis will be performed to investigate the effects of the randomisation unit.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Cross-over trials</HEADING>
<P>If, in future updates of this review, if cross-over trials are identified on this topic, and such trials are deemed eligible for inclusion, they will be included in the analyses with parallel group trials, using methods described by 
<LINK REF="REF-Elbourne-2002" TYPE="REFERENCE">Elbourne 2002</LINK>.</P>
</SUBSECTION>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2013-03-12 15:17:30 +0000" MODIFIED_BY="[Empty name]">
<P>For included studies, levels of attrition were noted. The impact of including studies with high levels of missing data in the overall assessment of treatment effect will be explored in future updates by using sensitivity analysis.</P>
<P>For all outcomes, analyses were carried out, as far as possible, on an intention-to-treat basis, i.e. the review author attempted to include all participants randomised to each group in the analyses, and all participants were analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2015-12-01 12:07:17 +0000" MODIFIED_BY="Heather Maxwell">
<P>Statistical heterogeneity was assessed in each meta-analysis using the Tau², I² and Chi² statistics. Heterogeneity was regarded as substantial if the I² was greater than 30% and either the Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. 
</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2015-12-01 12:07:23 +0000" MODIFIED_BY="Heather Maxwell">
<P>Had there been 10 or more studies in the meta-analysis, the review author planned to investigate reporting biases (such as publication bias) using funnel plots. In future updates, funnel plot asymmetry will be assessed visually. If asymmetry is suggested by a visual assessment, exploratory analyses will be performed to investigate it.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2015-12-01 12:07:36 +0000" MODIFIED_BY="Heather Maxwell">
<P>Statistical analysis was carried out using Review Manager software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). Fixed-effect meta-analyses were used for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and the trials&#8217; populations and methods were judged sufficiently similar. If there was clinical heterogeneity, sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, random-effects meta-analysis was used to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. The random-effects summary was treated as the average of the range of possible treatment effects and the review author discusses the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, trials were not combined.</P>
<P>Where random-effects analyses are used, the results are presented as the average treatment effect with its 95% confidence interval, and the estimates of  Tau² and I².</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2013-03-13 10:08:36 +0000" MODIFIED_BY="[Empty name]">
<P>Subgroup analysis was not carried out. </P>
<P>The review author carried out separate comparisons for two subgroups: based on whether the technique trialled assessed PR/RR relations or the ST segment. All outcomes were assessed in both groups of comparisons.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2015-12-01 12:07:46 +0000" MODIFIED_BY="Heather Maxwell">
<P>In future updates of this review, sensitivity analyses will be performed to explore outcomes with statistical heterogeneity and the effects of any assumptions made, such as the value of the ICC used for cluster-randomised trials (if appropriate).</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2015-12-21 13:06:57 +0000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2015-12-01 12:07:56 +0000" MODIFIED_BY="Heather Maxwell">
<P>A total of seven trials involving 27,403 women were identified that fulfilled the criteria for inclusion (<LINK REF="STD-Amer_x002d_Wahlin-2001" TYPE="STUDY">Amer-Wahlin 2001</LINK>; <LINK REF="STD-Belfort-2015" TYPE="STUDY">Belfort 2015</LINK>; <LINK REF="STD-Ojala-2006" TYPE="STUDY">Ojala 2006</LINK>; <LINK REF="STD-Strachan-2000" TYPE="STUDY">Strachan 2000</LINK>; <LINK REF="STD-Vayssiere-2007" TYPE="STUDY">Vayssiere 2007</LINK>; <LINK REF="STD-Westerhuis-2010" TYPE="STUDY">Westerhuis 2010</LINK>; <LINK REF="STD-Westgate-1993" TYPE="STUDY">Westgate 1993</LINK>).</P>
<SEARCH_RESULTS MODIFIED="2015-11-18 23:27:26 +0000" MODIFIED_BY="[Empty name]">
<P>The updated search retrieved five new reports (four trials), one was included in this 2015 update (<LINK REF="STD-Belfort-2015" TYPE="STUDY">Belfort 2015</LINK>): one was excluded (<LINK REF="STD-Ignatov-2012" TYPE="STUDY">Ignatov 2012</LINK>); one is awaiting classification (<LINK REF="STD-Gongora-2014" TYPE="STUDY">Gongora 2014</LINK>); and one is ongoing (<LINK REF="STD-Bach-2012" TYPE="STUDY">Bach 2012</LINK>).</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2015-12-01 12:07:56 +0000" MODIFIED_BY="Heather Maxwell">
<P>Out of the seven trials included, six were based on ST analysis (UK, Sweden, France, Finland, The Netherlands, USA) and one on PR length (multi-national). <I>See </I>
<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2015-11-30 17:09:29 +0000" MODIFIED_BY="Heather Maxwell">
<P>Five studies were excluded. Two studies were not randomised controlled trials (<LINK REF="STD-Hruban-2006" TYPE="STUDY">Hruban 2006</LINK>; <LINK REF="STD-Janku-2006" TYPE="STUDY">Janku 2006</LINK>), one study report was a review article (<LINK REF="STD-Olofsson-2003" TYPE="STUDY">Olofsson 2003</LINK>), one study did not involve analysis of fetal ECG waveform (<LINK REF="STD-Ignatov-2012" TYPE="STUDY">Ignatov 2012</LINK>), and one study was reported as abstract only with insufficient detail to include data (<LINK REF="STD-Prieto-2008" TYPE="STUDY">Prieto 2008</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2015-12-01 12:08:05 +0000" MODIFIED_BY="Heather Maxwell">
<P>For a summary of all 'Risk of bias' assessments, please refer to <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>.</P>
<ALLOCATION MODIFIED="2014-12-30 17:49:19 +0000" MODIFIED_BY="[Empty name]">
<P>Included trials were at low risk of selection bias.</P>
</ALLOCATION>
<BLINDING MODIFIED="2014-12-30 17:53:26 +0000" MODIFIED_BY="[Empty name]">
<P>Given the nature of the intervention, there was little scope for blinding women and their caregivers during labour. Blinding of observers who assessed the babies varied between studies.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2014-12-30 17:54:09 +0000" MODIFIED_BY="[Empty name]">
<P>Data were largely complete.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2014-12-30 17:54:39 +0000" MODIFIED_BY="[Empty name]">
<P>There was no suggestion of selective reporting. </P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2014-12-30 17:55:05 +0000" MODIFIED_BY="[Empty name]">
<P>There was no suggestion of other biases. </P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2015-12-21 13:06:57 +0000" MODIFIED_BY="[Empty name]">
<P>Seven trials (27,403 women) were included: six trials of ST waveform analysis (26,446 women) and one trial of PR interval analysis (957 women).</P>
<SUBSECTION>
<HEADING LEVEL="3">Comparison: Fetal electrocardiogram (ECG) plus cardiotocography (CTG) versus CTG alone</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>Seven trials (27,403 women) were included: six trials of ST waveform analysis (26,446 women) and one trial of PR interval analysis (957 women). The quality of evidence for ST waveform analysis trials was moderate to strong. In comparison to continuous electronic fetal heart rate monitoring alone, the use of adjunctive ST waveform analysis made no obvious difference to primary outcomes: births by caesarean section (RR 1.02, 95% CI 0.96 to 1.08; data from 26,446 women, 6 trials), <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>; the number of babies with severe metabolic acidosis at birth (cord arterial pH less than 7.05 and base deficit greater than 12 mmol/L) (average RR 0.72, 95% CI 0.43 to 1.20; data from 25,682 babies, 6 trials; Heterogeneity: I² = 55%, Tau² = 0.21), <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>; or babies with neonatal encephalopathy (RR 0.61, 95% CI 0.30 to 1.22; data from 26,410 babies, 6 trials), <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<P>As for secondary outcomes, there were on average fewer fetal scalp samples taken during labour (average RR 0.61, 95% CI 0.41 to 0.91; data from 9671 babies, 4 trials; Heterogeneity: I² = 92%, Tau² = 0.15), although the findings were heterogeneous and there were no data from the largest and most recent trial (from the USA), <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>; there were marginally fewer operative vaginal deliveries (RR 0.92, 95% CI 0.86 to 0.99; data from 26,446 women, 6 trials) <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>, but no obvious difference in the number of babies with low Apgar scores at five minutes (RR 0.95, 95% CI 0.73 to 1.24; data from 15302 babies, 5 trials) <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>; or babies requiring neonatal intubation (RR 1.37, 95% CI 0.89 to 2.11; data from 12544 babies, 2 trials) <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>, or babies requiring admission to the special care unit (RR 0.96, 95% CI 0.89 to 1.04; data from 26,410 babies, 6 trials) <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>. There were no differences in perinatal deaths (RR 1.71, 95% CI 0.67 to 4.33; data from 26,446 babies, 6 trials), <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>. No trial reported on the outcome cerebral palsy.</P>
<P>There was little evidence that monitoring by PR interval analysis conveyed any benefit.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2015-12-01 12:08:57 +0000" MODIFIED_BY="Heather Maxwell">
<SUMMARY_OF_RESULTS MODIFIED="2015-12-01 12:08:51 +0000" MODIFIED_BY="Heather Maxwell">
<P>Overall, the ST waveform trials have shown some very modest benefits in terms of process indicators, with less obstetric interference (specifically, fetal blood sampling and operative vaginal delivery), but they have not shown substantive clinical benefits (e.g. reduced encephalopathy) among women allocated to ST waveform analysis in addition to standard cardiotocography (CTG). The ST waveform trials used different generations of the same equipment (STAN recorder, Neoventa Medical, Gothenburg, Sweden). In the UK trial (<LINK REF="STD-Westgate-1993" TYPE="STUDY">Westgate 1993</LINK>), the T/QRS ratio provided the basis for identifying ST segment elevation. In the subsequent trials (<LINK REF="STD-Amer_x002d_Wahlin-2001" TYPE="STUDY">Amer-Wahlin 2001</LINK>; <LINK REF="STD-Ojala-2006" TYPE="STUDY">Ojala 2006</LINK>; <LINK REF="STD-Vayssiere-2007" TYPE="STUDY">Vayssiere 2007</LINK>; <LINK REF="STD-Westerhuis-2010" TYPE="STUDY">Westerhuis 2010</LINK>; <LINK REF="STD-Belfort-2015" TYPE="STUDY">Belfort 2015</LINK>), technical developments permitted the identification of ST waveform depression as well as elevation, since the former effect has also been seen in animal studies of experimentally-induced fetal hypoxaemia. Most trials were accompanied by regular education and training sessions for labour ward staff in both cardiotocogram and ECG waveform interpretation and these may be essential for optimal implementation.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2015-01-29 12:12:41 +0000" MODIFIED_BY="[Empty name]">
<P>Identification of studies seems to be complete. All studies were performed in high-income settings.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2015-12-01 12:08:57 +0000" MODIFIED_BY="Heather Maxwell">
<P>The trials were generally at low risk of bias for most 'Risk of bias' domains. The quality of evidence as assessed using the GRADE approach (see <A HREF="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html">GRADE handbook</A>) was graded moderate to high for ST waveform analysis trials (see <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). It was graded high for the following primary and secondary outcomes: caesarean section; neonatal encephalopathy; fetal blood sampling; operative vaginal delivery; admission to neonatal special care unit; and perinatal death. It was graded moderate for the following primary outcome: cord artery pH less than 7.05 and base deficit greater than 12 mmol/L. Downgrading for cord artery pH less than 7.05 and base deficit greater than 12 mmol/L was due to some heterogeneity in the findings.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2015-12-01 12:08:57 +0000" MODIFIED_BY="Heather Maxwell">
<P>A comprehensive search of the literature was conducted in order to minimise the possibility of publication bias. Only one review author assessed trials for inclusion and conducted data extraction and this is a potential bias of the review process. However, retrospective 'Risk of bias' assessments were conducted by more than one person (student medical statisticians) to minimise potential biases.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2014-12-30 18:46:17 +0000" MODIFIED_BY="[Empty name]">
<P>Five reported systematic reviews on this topic including four aggregate reviews (this Cochrane review included) and one individual patient data meta-analysis (<LINK REF="REF-Schuit-2013" TYPE="REFERENCE">Schuit 2013</LINK>) have been critiqued by <LINK REF="REF-Olofsson-2014" TYPE="REFERENCE">Olofsson 2014</LINK>.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2015-12-01 12:09:04 +0000" MODIFIED_BY="Heather Maxwell">
<IMPLICATIONS_PRACTICE MODIFIED="2015-12-01 12:09:04 +0000" MODIFIED_BY="Heather Maxwell">
<P>ST waveform trials have shown a modest reduction in operative deliveries and fetal blood sampling, but they have not shown substantive clinical benefits, and there was a lack of evidence regarding PR interval analysis. These findings provide some very modest support for the use of fetal ST waveform analysis when a decision has been made to undertake continuous electronic fetal heart rate monitoring during labour. However, in most labours, technically satisfactory cardiotocographic traces can be obtained by external ultrasound monitors, which are less invasive than internal scalp electrodes (which are required for electrocardiographic (ECG) analysis). The scalp electrode also cannot be used if the membranes are intact. One trial of fetal ECG analysis (<LINK REF="STD-Amer_x002d_Wahlin-2001" TYPE="STUDY">Amer-Wahlin 2001</LINK>) used guidelines for clinicians that recommended no action if cardiotocography (CTG) was normal, regardless of ST waveform analyses. This suggests that a better approach might be to consider using fetal ECG waveform analysis (of the ST waveform) only if CTG showed disquieting features.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2011-05-20 13:51:15 +0100" MODIFIED_BY="[Empty name]">
<P>The point estimates for effects of PR analysis are similar to those from the much larger ST studies, and the possibility of demonstrating beneficial effects from a larger PR trial could not be discounted. There is little information about the value of fetal ECG waveform monitoring in preterm fetuses in labour. Information about long-term development of the babies included in the trials would be valuable.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2015-12-01 12:09:11 +0000" MODIFIED_BY="Heather Maxwell">
<P>Thanks for additional unpublished data from Dr Jenny Westgate (<LINK REF="STD-Westgate-1993" TYPE="STUDY">Westgate 1993</LINK>), Dr Christophe Vayssiere (<LINK REF="STD-Vayssiere-2007" TYPE="STUDY">Vayssiere 2007</LINK>), and Prof Karel Marsal (<LINK REF="STD-Amer_x002d_Wahlin-2001" TYPE="STUDY">Amer-Wahlin 2001</LINK>).</P>
<P>Thanks also to Becky Davie and Sally Reynolds, student medical statisticians, who helped with the 'Risk of bias' assessments of included studies (and to Leanne Jones for her oversight).</P>
<P>This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to Cochrane Pregnancy and Childbirth. The views and opinions expressed therein are those of the author and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.<BR/> </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2011-06-15 11:58:30 +0100" MODIFIED_BY="Denise Atherton">
<P>JP Neilson has prepared and maintained the review. </P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2015-12-14 12:17:41 +0000" MODIFIED_BY="[Empty name]">
<P>Methods updated. A 'Summary of findings' table has been added. </P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2015-11-30 18:30:11 +0000" MODIFIED_BY="Heather Maxwell">
<STUDIES MODIFIED="2015-11-30 18:17:29 +0000" MODIFIED_BY="Heather Maxwell">
<INCLUDED_STUDIES MODIFIED="2015-11-30 18:17:29 +0000" MODIFIED_BY="Heather Maxwell">
<STUDY DATA_SOURCE="PUB" ID="STD-Amer_x002d_Wahlin-2001" MODIFIED="2013-03-25 15:55:21 +0000" MODIFIED_BY="[Empty name]" NAME="Amer-Wahlin 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-03-06 09:42:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Amer-Wahlin I, Hellsten C, Noren H, Hagberg H, Herbst A, Kjellmer I, et al</AU>
<TI>Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial</TI>
<SO>Lancet</SO>
<YR>2001</YR>
<VL>358</VL>
<PG>534-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;[14902]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Amer-Wahlin I, Kallen K, Herbst A, Rydhstroem H, Sundstrom AK, Marsal K</AU>
<TI>Implementation of new medical techniques: experience from the Swedish randomized controlled trial on fetal ecg during labor</TI>
<SO>Journal of Maternal-Fetal &amp; Neonatal Medicine</SO>
<YR>2005</YR>
<VL>18</VL>
<NO>2</NO>
<PG>93-100</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-03-06 09:39:21 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Amer-Wahlin I, Kjellmer I, Marsal K, Olofsson P, Rosen KG</AU>
<TI>Swedish randomized controlled trial of cardiotocography versus cardiotocography plus ST analysis of fetal electrocardiogram revisited: analysis of data according to standard versus modified intention-to-treat principle</TI>
<SO>Acta Obstetrica et Gynecologica Scandinavica</SO>
<YR>2011</YR>
<VL>90</VL>
<NO>9</NO>
<PG>990-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-06-06 12:53:37 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Amer-Wahlin I, Marsal K, Noren H, Hellsten C</AU>
<TI>Randomized controlled trial of CTG versus CTG + ST analysis of the fetal ECG</TI>
<SO>XVI FIGO World Congress of Obstetrics and Gynecology (Book 3); 2000 Sept 3-8; Washington DC, USA</SO>
<YR>2000</YR>
<PG>35</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-03-06 09:42:06 +0000" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hagberg H, Amer-Wahlin I, Hellsten C, Noren H, Herbst A, Lilja H, et al</AU>
<TI>Intrapartum fetal monitoring: cardiotocography versus cardiotocography plus fetal ECG ST waveform analysis. A Swedish randomized controlled trial</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2001</YR>
<VL>184</VL>
<NO>1</NO>
<PG>S19</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-03-06 09:34:53 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hanson J</AU>
<TI>Cardiotocography and ST analysis for intrapartum fetal monitoring</TI>
<SO>Lancet</SO>
<YR>2011</YR>
<VL>378</VL>
<NO>9797</NO>
<PG>1137-8</PG>
<IDENTIFIERS MODIFIED="2011-10-03 10:31:46 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE MODIFIED="2011-06-06 12:32:43 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Lund University</AU>
<SO>Decision</SO>
<YR>16 September 2010</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-03-06 09:34:12 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marsal K</AU>
<TI>Cardiotocography and ST analysis for intrapartum fetal monitoring - author's reply</TI>
<SO>Lancet</SO>
<YR>2011</YR>
<VL>378</VL>
<NO>9797</NO>
<PG>1138</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-06-06 12:33:00 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Marsal K</AU>
<SO>Personal communication</SO>
<YR>7th January 2011</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-03-25 15:55:21 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[12732]&lt;/p&gt;" NOTES_MODIFIED="2013-03-25 15:55:21 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Noren H, Amer-Wahlin I, Hagberg H, Herbst A, Kjellmer I, Marsal K, et al</AU>
<TI>Fetal electrocardiography in labor and neonatal outcome: data from the Swedish randomized controlled trial on intrapartum fetal monitoring</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2003</YR>
<VL>188</VL>
<NO>1</NO>
<PG>183-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Noren H, STAN study group</AU>
<TI>Randomised controlled trial of CTG versus CTG + ST analysis of the fetal ECG</TI>
<SO>Prenatal and Neonatal Medicine</SO>
<YR>2000</YR>
<VL>5</VL>
<NO>Suppl 2</NO>
<PG>37</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-11 14:50:03 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sundstrom AK, Swedish STAN Group</AU>
<TI>Randomised controlled trial CTG versus CTG + ST analysis of the fetal ECG</TI>
<SO>Journal of Obstetrics and Gynecology</SO>
<YR>2001</YR>
<VL>21</VL>
<NO>Suppl 1</NO>
<PG>S18-S19</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-06-06 12:35:10 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="OTHER">
<AU>Swedish Research Council</AU>
<TI>Opinion provided on request for investigation of suspected misconduct in research - the STAN study</TI>
<SO>Log no 312-2008-7602</SO>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Belfort-2015" MODIFIED="2015-11-30 18:17:29 +0000" MODIFIED_BY="Heather Maxwell" NAME="Belfort 2015" YEAR="2015">
<REFERENCE MODIFIED="2015-11-30 18:17:29 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Belfort MA, Saade GR, Thom E, Blackwell SC, Reddy UM, Thorp JM, et al; for the Eunice Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network</AU>
<TI>A randomized trial of intrapartum fetal ECG ST-segment analysis</TI>
<SO>New England Journal of Medicine</SO>
<YR>2015</YR>
<VL>373</VL>
<PG>632-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-11-18 23:09:00 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Saade G; for Eunice Shriver NICHD Network</AU>
<TI>Fetal ECG analysis of the ST segment as an adjunct to intrapartum fetal heart rate monitoring: a randomized clinical trial</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2015</YR>
<VL>212</VL>
<NO>1 Suppl 1</NO>
<PG>S2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ojala-2006" NAME="Ojala 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ojala K, Vääräsmäki M, Mäkikallio K, Valkama M, Tekay A</AU>
<TI>A comparison of intrapartum automated fetal electrocardiography and conventional cardiotocography&#8212;a randomised controlled study</TI>
<SO>BJOG: an international journal of obstetrics and gynaecology</SO>
<YR>2006</YR>
<VL>113</VL>
<PG>419-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Strachan-2000" MODIFIED="2012-03-06 09:40:55 +0000" MODIFIED_BY="[Empty name]" NAME="Strachan 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-03-06 09:40:49 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Strachan BK, van Wijngaarden WJ, Sahota D, Chang A, James DK; for the FECG Study Group</AU>
<TI>Cardiotocography only versus cardiotocography plus PR-interval analysis in intrapartum surveillance: a randomised, multicentre trial</TI>
<SO>Lancet</SO>
<YR>2000</YR>
<VL>355</VL>
<PG>456-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-03-06 09:40:55 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Wijngaarden WJ, Sahota DS, James DK, Farrell T, Mires GJ, Wilcox M, et al</AU>
<TI>Improved intrapartum surveillance with PR interval analysis of the fetal electrocardiogram: a randomised trial showing a reduction in fetal blood sampling</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1996</YR>
<VL>174</VL>
<PG>1295-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Wijngaarden WJ, Sahota DS, James DK, Symonds EM, Farrell T, Mires G</AU>
<TI>Does the fetal ECG improve intrapartum surveillance? II: A prospective evaluation</TI>
<SO>International Journal of Gynecology &amp; Obstetrics</SO>
<YR>1994</YR>
<VL>46</VL>
<NO>Suppl 2</NO>
<PG>102</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vayssiere-2007" MODIFIED="2013-03-25 15:31:05 +0000" MODIFIED_BY="[Empty name]" NAME="Vayssiere 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-03-06 09:41:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vayssiere C, David E, Haberstich R, Sebahoun V, Roth E, Meyer N, et al</AU>
<TI>A French randomized controlled trial on ST analysis in a population with abnormal FHR in labor</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2006</YR>
<VL>195</VL>
<NO>6 Suppl 1</NO>
<PG>S222</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-03-25 15:31:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Vayssiere C, David E, Meyer N, Haberstich R, Sebahoun V, Roth E, et al</AU>
<TI>A French randomized controlled trial of ST-segment analysis in a population with abnormal cardiotocograms during labor</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2007</YR>
<VL>197</VL>
<NO>3</NO>
<PG>299.e1-e6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Westerhuis-2010" MODIFIED="2013-02-14 10:30:37 +0000" MODIFIED_BY="[Empty name]" NAME="Westerhuis 2010" YEAR="2010">
<REFERENCE MODIFIED="2010-06-11 16:10:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Becker J, Westerhuis M, Sterrenburg K, Kwee A, Visser G</AU>
<TI>Fetal blood sampling in the Dutch STAN-trial: reason to adjust the clinical guidelines?</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2009</YR>
<VL>201</VL>
<NO>6 Suppl 1</NO>
<PG>S240</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-03-06 09:37:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Becker JH, Westerhuis ME, Sterrenburg K, van den Akker ES, van Beek E, Bolte AC, et al</AU>
<TI>Fetal blood sampling in addition to intrapartum ST-analysis of the fetal electrocardiogram: evaluation of the recommendations in the Dutch STAN(R) trial</TI>
<SO>BJOG: an international journal of obstetrics and gynaecology</SO>
<YR>2011</YR>
<VL>118</VL>
<NO>10</NO>
<PG>1239-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-03-06 09:19:21 +0000" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="OTHER">
<AU>Kwee A, Visser GHA</AU>
<TI>The cost-effectiveness of ST-analysis of the fetal electrocardiogram as compared to fetal blood sampling for intrapartum monitoring: a randomised controlled trial</TI>
<SO>Netherlands Trial Register (http://www.trialregister.nl)</SO>
<YR>(accessed 1 November 2005)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-06-11 16:10:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kwee A</AU>
<TI>Cardiotocography plus ST-analysis of the fetal electrocardiogram versus cardiotocography only for intrapartum monitoring: a Dutch randomized trial</TI>
<SO>Journal of Perinatal Medicine</SO>
<YR>2009</YR>
<VL>37</VL>
<NO>Suppl 1</NO>
<PG>66</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-03-06 09:41:25 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vijgen SMC, Westerhuis MEMH, Opmeer BC, Visser GHA, Moons KGM, Porath MM, et al</AU>
<TI>Cost-effectiveness of cardiotocography plus ST analysis of the fetal electrocardiogram compared with cardiotocography alone</TI>
<SO>Acta Obstetrica et Gynecologica Scandinavica</SO>
<YR>2011</YR>
<VL>90</VL>
<NO>7</NO>
<PG>772-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-06-06 12:44:52 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Westerhuis ME, Moons KG, van Beek E, Bijvoet SM, Drogtrop AP, van Geijn HP, et al</AU>
<TI>A randomised clinical trial on cardiotocography plus fetal blood sampling versus cardiotocography plus ST-analysis of the fetal electrocardiogram (STAN) for intrapartum monitoring</TI>
<SO>BMC Pregnancy and Childbirth</SO>
<YR>2007</YR>
<VL>7</VL>
<PG>13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-06-06 12:22:13 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Westerhuis ME, Visser GH, Moons KG, van Beek E, Benders MJ, Bijvoet SM, et al</AU>
<TI>Cardiotocography plus ST analysis of fetal electrocardiogram compared with cardiotocography only for intrapartum monitoring: a randomized controlled trial</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>2010</YR>
<VL>115</VL>
<NO>6</NO>
<PG>1173-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-02-14 10:30:32 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Westerhuis MEMH, Porath MM, Becker JH, Van Den Akker ESA, Van Beek E, Van Dessel HJHM, et al</AU>
<TI>Identification of cases with adverse neonatal outcome monitored by cardiotocography versus ST analysis: Secondary analysis of a randomized trial</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>2012</YR>
<VL>91</VL>
<NO>7</NO>
<PG>830-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-06-06 12:27:14 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Westerhuis MEMH, Visser GHA, Moons KGM, Zuithoff NPA, Mol BWJ, Kwee A</AU>
<TI>Cardiotocography plus ST analysis of fetal electrocardiogram compared with cardiotocography only for intrapartum monitoring: a randomized controlled trial</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>2011</YR>
<VL>117</VL>
<PG>406-7; 412</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Westgate-1993" MODIFIED="2013-03-25 15:34:14 +0000" MODIFIED_BY="Heather Maxwell" NAME="Westgate 1993" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Westgate J, Harris M, Curnow J, Greene K</AU>
<TI>Plymouth randomised controlled trial of 2400 cases - ST waveform plus CTG vs CTG alone for intrapartum monitoring</TI>
<SO>Proceedings of 26th British Congress of Obstetrics and Gynaecology; 1992; Manchester, UK</SO>
<YR>1992</YR>
<PG>177</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;[7248]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Westgate J, Harris M, Curnow JSH, Green KR</AU>
<TI>Randomized trial of cardiotocography alone or with ST waveform analysis for intrapartum monitoring</TI>
<SO>Lancet</SO>
<YR>1992</YR>
<VL>340</VL>
<PG>194-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Westgate J, Harris M, Curnow JSH, Greene KR</AU>
<TI>Plymouth randomized trial of CTG vs ST waveform analysis plus CTG for intrapartum monitoring: 2400 cases</TI>
<SO>Journal of Perinatal Medicine</SO>
<YR>1992</YR>
<VL>20</VL>
<NO>1</NO>
<PG>268</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-03-25 15:34:14 +0000" MODIFIED_BY="Heather Maxwell" NOTES="&lt;p&gt;[7911]&lt;/p&gt;" NOTES_MODIFIED="2013-03-25 15:34:14 +0000" NOTES_MODIFIED_BY="Heather Maxwell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Westgate J, Harris M, Curnow JSH, Greene KR</AU>
<TI>Plymouth randomized trial of cardiotocogram only vs ST waveform plus cardiotocogram for intrapartum monitoring in 2400 cases</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1993</YR>
<VL>169</VL>
<PG>1151-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2014-12-30 16:10:42 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Hruban-2006" MODIFIED="2012-03-06 09:42:26 +0000" MODIFIED_BY="[Empty name]" NAME="Hruban 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-03-06 09:42:26 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hruban L, Janku P, Zahradnickova J, Kurecova B, Roztocil A, Kachlík P, et al</AU>
<TI>Role of ST-analysis of fetal ECG in intrapartal fetus monitoring with presumed growth retardation</TI>
<SO>Ceska Gynekologie</SO>
<YR>2006</YR>
<VL>71</VL>
<NO>4</NO>
<PG>268-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ignatov-2012" MODIFIED="2014-12-30 16:10:42 +0000" MODIFIED_BY="[Empty name]" NAME="Ignatov 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-12-30 16:10:42 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ignatov P, Atanasov B</AU>
<TI>[Indirect standard cardiotocography plus fetal blood sampling versus indirect quantitative cardiotocography--a randomized comparative study in intrapartum monitoring]. [Bulgarian]</TI>
<SO>Akusherstvo i Ginekologiia</SO>
<YR>2012</YR>
<VL>51</VL>
<NO>5</NO>
<PG>3-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Janku-2006" MODIFIED="2009-04-27 13:32:27 +0100" MODIFIED_BY="[Empty name]" NAME="Janku 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-04-27 13:32:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Janku P, Hruban L, Kurecova B, Roztocil A, Kachlik P, Zahradnickova J</AU>
<TI>ST analysis of fetal ECG in premature deliveries during 30th-36th week of pregnancy</TI>
<SO>Ceska Gynekologie</SO>
<YR>2006</YR>
<VL>71</VL>
<NO>3</NO>
<PG>163-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Olofsson-2003" NAME="Olofsson 2003" YEAR="2003">
<REFERENCE NOTES="&lt;p&gt;[13319]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Olofsson P</AU>
<TI>Current status of intrapartum fetal monitoring: cardiotocography versus cardiotocography + ST analysis of the fetal ECG</TI>
<SO>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</SO>
<YR>2003</YR>
<VL>110</VL>
<PG>S113-S118</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Prieto-2008" MODIFIED="2011-05-19 15:42:38 +0100" MODIFIED_BY="[Empty name]" NAME="Prieto 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-05-19 15:42:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Prieto AP, Pareja MV, Zuniga IV, Romero TA, Leon MDR, Ventoso FM</AU>
<TI>Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing</TI>
<SO>Journal of Maternal-Fetal and Neonatal Medicine</SO>
<YR>2008</YR>
<VL>21</VL>
<NO>Suppl 1</NO>
<PG>141</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2015-01-21 10:16:04 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Gongora-2014" MODIFIED="2015-01-21 10:16:04 +0000" MODIFIED_BY="[Empty name]" NAME="Gongora 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-01-21 10:16:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gongora RJ, Naveiro SM, Ruiz DS, Puertas PA, Barranco AM, Carrillo BMP</AU>
<TI>A comparison of intrapartum fetal electrocardiography versus conventional cardiotocography in prolonged gestations: preliminary results</TI>
<SO>Journal of Maternal-Fetal &amp; Neonatal Medicine</SO>
<YR>2014</YR>
<VL>27</VL>
<NO>Suppl 1</NO>
<PG>265</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2014-12-30 16:11:10 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bach-2012" MODIFIED="2014-12-30 16:11:10 +0000" MODIFIED_BY="[Empty name]" NAME="Bach 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-12-30 16:11:10 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Bach D, Secher NJ</AU>
<TI>Cardiotocography combined with ST-analysis versus cardiotocography combined with scalp-pH in deliveries with abnormal CTG - a randomised trial</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 3 August 2014]</SO>
<YR>2012</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS>
<IDENTIFIER TYPE="CTG" VALUE="NCT01699646"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Spong-2013" MODIFIED="2014-08-06 12:19:12 +0100" MODIFIED_BY="[Empty name]" NAME="Spong 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-08-06 12:19:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Spong C</AU>
<TI>Fetal ST segment and T wave analysis in labor (STAN)</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/)</SO>
<YR>2010</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-02-14 10:31:25 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-02-14 10:31:25 +0000" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT01131260"/>
</IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2015-11-30 18:30:11 +0000" MODIFIED_BY="Heather Maxwell">
<ADDITIONAL_REFERENCES MODIFIED="2015-11-30 18:30:11 +0000" MODIFIED_BY="Heather Maxwell">
<REFERENCE ID="REF-Alfirevic-2013" MODIFIED="2014-12-30 17:11:05 +0000" MODIFIED_BY="[Empty name]" NAME="Alfirevic 2013" TYPE="COCHRANE_REVIEW">
<AU>Alfirevic Z, Devane D, Gyte GML</AU>
<TI>Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>5</NO>
<IDENTIFIERS MODIFIED="2008-11-11 14:45:23 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-11-11 14:45:23 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006066"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Amer_x002d_Wahlin-2011" MODIFIED="2012-03-06 09:39:04 +0000" MODIFIED_BY="[Empty name]" NAME="Amer-Wahlin 2011" TYPE="JOURNAL_ARTICLE">
<AU>Amer-Wahlin I, Kjellmer I, Marsal K, Olofsson P, Rosen KG</AU>
<TI>Swedish randomized controlled trial of cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram revisited: Analysis of data according to standard versus modified intention-to-treat principle</TI>
<SO>Acta Obstetrica et Gynecologica Scandinavica</SO>
<YR>2011</YR>
<VL>90</VL>
<NO>9</NO>
<PG>990-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dawes-1994" NAME="Dawes 1994" TYPE="JOURNAL_ARTICLE">
<AU>Dawes G, Meir YJ, Mandruzzato GP</AU>
<TI>Computerized evaluation of fetal heart rate patterns</TI>
<SO>Journal of Perinatal Medicine</SO>
<YR>1994</YR>
<VL>22</VL>
<PG>491-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Elbourne-2002" MODIFIED="2009-05-07 11:00:45 +0100" MODIFIED_BY="[Empty name]" NAME="Elbourne 2002" TYPE="JOURNAL_ARTICLE">
<AU>Elbourne DR, Altman DG, Higgins JPT, Curtin F, Vaillancourt JM</AU>
<TI>Meta-analyses involving cross-over trials: methodological issues</TI>
<SO>International Journal of Epidemiology</SO>
<YR>2002</YR>
<VL>31</VL>
<PG>140-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Greene-1987" MODIFIED="2015-01-21 10:27:49 +0000" MODIFIED_BY="[Empty name]" NAME="Greene 1987" TYPE="BOOK_SECTION">
<AU>Greene KG</AU>
<TI>The ECG waveform</TI>
<SO>Bailliere's Clinical Obstetrics and Gynaecology</SO>
<YR>1987</YR>
<VL>1</VL>
<PG>131-55</PG>
<ED>Whittle M</ED>
<PB>Bailliere Tindall</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Greene-1999" MODIFIED="2013-03-25 15:38:26 +0000" MODIFIED_BY="Lynn Hampson" NAME="Greene 1999" TYPE="BOOK_SECTION">
<AU>Greene K</AU>
<TI>Intrapartum fetal monitoring: CTG, ECG and fetal blood sampling</TI>
<SO>Fetal Medicine: Basic Science and Clinical Practice</SO>
<YR>1999</YR>
<PG>985-1004</PG>
<ED>Rodeck CH, Whittle MJ</ED>
<PB>Churchill Livingstone</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2011-06-06 12:46:56 +0100" MODIFIED_BY="Lynn Hampson" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marsal-2011" MODIFIED="2012-03-06 09:34:23 +0000" MODIFIED_BY="[Empty name]" NAME="Marsal 2011" TYPE="JOURNAL_ARTICLE">
<AU>Marsal K</AU>
<TI>Cardiotocography and ST analysis for intrapartum fetal monitoring - author's reply</TI>
<SO>Lancet</SO>
<YR>2011</YR>
<VL>378</VL>
<NO>9797</NO>
<PG>1138</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Olofsson-2014" MODIFIED="2015-11-30 18:28:31 +0000" MODIFIED_BY="Heather Maxwell" NAME="Olofsson 2014" TYPE="JOURNAL_ARTICLE">
<AU>Olofsson P, Ayres-de-Campos D, Kessler J, Tendal B, Yli BM, Devoe L</AU>
<TI>A critical appraisal of the evidence for using cardiotocography plus ECG ST waveform analysis for fetal surveillance in labor. Part II: the meta-analyses</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>2014</YR>
<VL>93</VL>
<PG>571-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2014-08-19 13:21:08 +0100" MODIFIED_BY="Leanne V Jones" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rosen-1989" NAME="Rosen 1989" TYPE="JOURNAL_ARTICLE">
<AU>Rosen KG, Lindecrantz K</AU>
<TI>STAN - the Gothenburg model for fetal surveillance during labour by ST analysis of the fetal ECG</TI>
<SO>Clinical Physics and Physiological Measurement</SO>
<YR>1989</YR>
<VL>10</VL>
<NO>Suppl B</NO>
<PG>51-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rosen-1991" MODIFIED="2012-03-06 09:44:04 +0000" MODIFIED_BY="[Empty name]" NAME="Rosen 1991" TYPE="BOOK_SECTION">
<AU>Rosen KG, Arulkumaran S, Greene KR, Lilja H, Lindecrantz K, Seneviratne H, et al</AU>
<TI>Clinical validity of fetal ECG waveform analysis</TI>
<SO>Perinatology. Nutrition Workshop Series</SO>
<YR>1991</YR>
<VL>26</VL>
<PG>95-110</PG>
<ED>Saling E</ED>
<PB>Raven Press</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schuit-2013" MODIFIED="2015-11-30 18:30:11 +0000" MODIFIED_BY="Heather Maxwell" NAME="Schuit 2013" TYPE="JOURNAL_ARTICLE">
<AU>Schuit E, Amer-Wahlin I, Ojala K, Vayssiere C, Westerhuis MEMH, Marsal K, et al</AU>
<TI>Effectiveness of electronic fetal monitoring with additional ST analysis in vertex singleton pregnancies beyond 36 weeks of gestation: an individual participant data meta-analysis</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2013</YR>
<VL>208</VL>
<PG>187.e1-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Swedish-Research-Council-2010" MODIFIED="2012-03-06 09:45:36 +0000" MODIFIED_BY="[Empty name]" NAME="Swedish Research Council 2010" TYPE="OTHER">
<AU>Swedish Research Council</AU>
<TI>Opinion provided on request for investigation of suspected misconduct in research - the STAN study</TI>
<SO>Log no 312-2008-7602</SO>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2014-08-19 13:19:31 +0100" MODIFIED_BY="Leanne V Jones">
<REFERENCE ID="REF-Neilson--1995" NAME="Neilson  1995" TYPE="OTHER">
<AU>Neilson JP</AU>
<TI>Intrapartum fetal ECG plus heart rate recording. [revised 12 May 1994]</TI>
<SO>In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds) Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Neilson-2003" MODIFIED="2013-03-25 15:42:14 +0000" MODIFIED_BY="[Empty name]" NAME="Neilson 2003" TYPE="COCHRANE_REVIEW">
<AU>Neilson JP Reviews</AU>
<TI>Fetal electrocardiogram (ECG) for fetal monitoring during labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>2</NO>
<EN>Neilson JP. Fetal electrocardiogram (ECG) for fetal monitoring during labour. The Cochrane Database of Systematic Reviews 2003, Issue 2. Art. No.: CD000116. DOI: 10.1002/14651858.CD000116.</EN>
<IDENTIFIERS MODIFIED="2013-03-12 16:19:13 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-03-12 16:19:13 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000116"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Neilson-2006" MODIFIED="2011-06-06 12:52:40 +0100" MODIFIED_BY="Lynn Hampson" NAME="Neilson 2006" TYPE="COCHRANE_REVIEW">
<AU>Neilson JP</AU>
<TI>Fetal electrocardiogram (ECG) for fetal monitoring during labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2011-06-06 12:52:29 +0100" MODIFIED_BY="Lynn Hampson">
<IDENTIFIER MODIFIED="2011-06-06 12:52:29 +0100" MODIFIED_BY="Lynn Hampson" TYPE="DOI" VALUE="10.1002/14651858.CD000116.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Neilson-2012" MODIFIED="2013-03-25 15:40:38 +0000" MODIFIED_BY="[Empty name]" NAME="Neilson 2012" TYPE="COCHRANE_REVIEW">
<AU>Neilson JP</AU>
<TI>Fetal electrocardiogram (ECG) for fetal monitoring during labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2013-02-14 10:48:17 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-02-14 10:48:17 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000116.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Neilson-2013" MODIFIED="2014-08-19 13:19:31 +0100" MODIFIED_BY="Leanne V Jones" NAME="Neilson 2013" TYPE="COCHRANE_REVIEW">
<AU>Neilson JP</AU>
<TI>Fetal electrocardiogram (ECG) for fetal monitoring during labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>5</NO>
<IDENTIFIERS MODIFIED="2014-08-19 13:19:27 +0100" MODIFIED_BY="Leanne V Jones">
<IDENTIFIER MODIFIED="2014-08-19 13:19:27 +0100" MODIFIED_BY="Leanne V Jones" TYPE="DOI" VALUE="10.1002/14651858.CD000116.pub4"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2008-11-11 14:31:15 +0000" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2015-12-01 11:57:10 +0000" MODIFIED_BY="Heather Maxwell">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2015-12-01 11:57:10 +0000" MODIFIED_BY="Heather Maxwell" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2015-12-01 11:56:29 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Amer_x002d_Wahlin-2001">
<CHAR_METHODS>
<P>Random allocation through computer-generated random numbers table, triggered by switching on the software in the fetal monitoring equipment.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-12-01 11:56:29 +0000" MODIFIED_BY="Heather Maxwell">
<P>4966 women in labour at &gt; 36 weeks with singleton pregnancies, cephalic presentation and perceived need for continuous fetal heart rate monitoring via a fetal scalp electrode - high-risk pregnancies, suspicious or abnormal CTG, induced labour, oxytocin augmentation, meconium-stained amniotic fluid or epidural analgesia. The trial took place between 1998 and 2000 in 3 Swedish centres, Lund, Malmo, Gothenburg.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-11-30 16:29:06 +0000" MODIFIED_BY="Heather Maxwell">
<P>CTG plus ST analysis of fetal ECG (2519 women) versus CTG alone (2477). The monitoring device was the STAN S21 (Neoventa Medical, Gothenburg), which incorporates an 'expert system' to provide advice to clinical staff. In this, it constitutes a technically more advanced system than used in the <LINK REF="STD-Westgate-1993" TYPE="STUDY">Westgate 1993</LINK> trial.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-06-15 11:59:24 +0100" MODIFIED_BY="Denise Atherton">
<P>Primary: metabolic acidosis at birth (umbilical cord artery pH &lt; 7.05 plus base deficit &gt; 12 mmol/L). Secondary: operative deliveries, Apgar scores at 1 and 5 minutes, admissions to special care unit.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-03-25 15:44:27 +0000" MODIFIED_BY="[Empty name]">
<P>Incomplete data available for acid-base results (2159 and 2079). The published report includes a secondary analysis performed after exclusion of babies with malformations and cases associated with trial protocol violations. The results included in this review are exclusively from the primary analysis, based on 'intention-to-treat'. An interim analysis was performed after around 1800 recruits; this revealed 'protocol violations' (failure to intervene on the basis of guidance in the research protocol) and the interim results were discussed with the clinical staff at the recruiting centres as part of a process of 're-training'. The study was co-funded by the Swedish Government Public Health Service, Neoventa Medical AB (manufacturer of the STAN device) and the Knowledge Foundation, Stockholm.</P>
<P>Concerns were raised about the conduct and reporting of this trial, resulting in 3 separate external reviews. The final review (<LINK REF="REF-Swedish-Research-Council-2010" TYPE="REFERENCE">Swedish Research Council 2010</LINK>) was critical of the role of the originator of the STAN device role as the monitor of trial - because of conflicted interests. The report also required the re-reporting of cord gas results (these have been corrected in the review and have now been published (<LINK REF="REF-Amer_x002d_Wahlin-2011" TYPE="REFERENCE">Amer-Wahlin 2011</LINK>; <LINK REF="REF-Marsal-2011" TYPE="REFERENCE">Marsal 2011</LINK>) but other reported outcomes were not in dispute. There was no suggestion of deliberate attempts to manipulate the data (University of Lund 2010).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-12-01 11:56:37 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Belfort-2015">
<CHAR_METHODS MODIFIED="2015-09-23 17:38:13 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-09-23 17:37:18 +0100" MODIFIED_BY="[Empty name]">
<P>11,108 women with singleton fetuses, &gt; 36 weeks, attempting vaginal delivery, cervical dilatation 2-7 cms. Recruitment in one of 26 hospitals in network in USA, between November 2010 and March 2014. All hospitals had pilot experience of using ST-segment analysis equipment in at least 50 labours.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-12-01 11:56:37 +0000" MODIFIED_BY="Heather Maxwell">
<P>The experimental group had results of fetal ECG ST-segment analysis revealed as adjunct to CTG findings; in the control group, the fetal ECG ST-segment analysis results were concealed ('masked').</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-09-24 11:30:10 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome: composite of intrapartum fetal death, neonatal death, Apgar score &gt; 4 at 5 minutes, neonatal seizure, umbilical artery blood pH of 7.05 or less with base deficit of 12 mmol/L or more, intubation for ventilation at delivery, or neonatal encephalopathy. Maternal secondary outcomes: caesarean birth, assisted vaginal birth, chorioamnionitis, maternal blood transfusion, duration of labour, shoulder dystocia, postpartum endometritis, length of hospital stay. Neonatal secondary outcomes: components of primary outcome - Apgar score at 5 minutes, umbilical artery blood gas results, admission to intermediate care nursery or neonatal intensive care unit.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-24 10:21:55 +0100" MODIFIED_BY="[Empty name]">
<P>Intention to treat analysis. A 'protocol sub-committee' review of a sub-set of records in the revealed group found, retrospectively, that in some cases, management protocols were not followed correctly by clinical staff. Thus of 2427 women who were assigned to the open group and who had records assessed,163 (6.7%) did not receive care according to STAN guidelines with 95 (3.9%) not receiving expedited delivery when recommended, and 68 (2.8%) having delivery expedited despite recommendation for continued observation.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-06-15 12:00:13 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Ojala-2006">
<CHAR_METHODS>
<P>Opaque, consecutively numbered, sealed, envelopes containing randomisation code generated by computer programme in blocks of 100. Envelope opened at time of amniotomy.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-06-15 12:00:13 +0100" MODIFIED_BY="Denise Atherton">
<P>1483 women randomised; 11 exclusions; clinical data available but blood gas data missing for 36. In labour at =/&gt; 36 weeks with singleton fetus, cephalic presentation, decision to perform amniotomy, no contraindication to scalp electrode. Sample size based on 50% reduction of umbilical artery pH &lt; 7.10.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>CTG plus ECG waveform analysis (STAN) (733 women) versus CTG (739 women). Fetal scalp sampling for pH estimation an option in either group. Recruitment in tertiary referral hospital in Finland 2003-4.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Neonatal acidaemia, operative delivery, need for fetal scalp sampling for pH estimation.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>In 83 pregnancies, there were technical difficulties in achieving satisfactory monitoring - n = 5 in CTG group; n = 78 in the ECG group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-12-01 11:56:47 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Strachan-2000">
<CHAR_METHODS>
<P>Random allocation through computer-generated random numbers table, triggered by switching on the software in the fetal monitoring equipment.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-12-01 11:56:47 +0000" MODIFIED_BY="Heather Maxwell">
<P>957 women in labour with perceived need for continuous fetal heart rate monitoring (age &gt; 35, maternal disease, adverse obstetric history, prematurity, suspected fetal growth restriction, antepartum haemorrhage, breech presentation, multiple pregnancy, epidural analgesia, induction or augmentation of labour, abnormal CTG, meconium, previous caesarean section). Results are only available for 957 women (92%) for reasons that are unclear. The trial took place in 5 centres: Nottingham and Dundee (UK), Hong Kong, Amsterdam (The Netherlands) and Singapore.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>CTG plus fetal ECG (n = 482) versus CTG alone (n = 475).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>The trial was powered to detect (alpha 80%, beta 5%) a decrease in 'unsuspected acidaemia' (cord artery pH &lt; 7.15) from 8.5% to 4.5%.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>The data monitoring committee recommended that the trial be stopped before recruitment of the target of 1192 for reasons that are not clear from the report.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-12-01 11:56:54 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Vayssiere-2007">
<CHAR_METHODS MODIFIED="2011-06-15 12:02:57 +0100" MODIFIED_BY="Denise Atherton">
<P>Sealed, numbered, opaque envelopes were prepared in a Research Unit. Details of randomisation are not described but there was stratification by centre (2). Allocation was by opening the next envelope.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-12-01 11:56:54 +0000" MODIFIED_BY="Heather Maxwell">
<P>799 women in labor at 36 weeks or more, with a single fetus with cephalic presentation, and either abnormal cardiotocographic trace or thick meconium-stained amniotic fluid. Exclusions included maternal infections that contraindicated scalp electrode attachment (e.g. HIV), cardiac malformation, severely abnormal CTG at the time of recruitment.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-09-24 15:22:36 +0100" MODIFIED_BY="[Empty name]">
<P>CTG + fetal ECG (n = 399) versus CTG alone (n = 400). Scalp sampling for pH estimation was an option in both groups.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-10 12:41:05 +0000" MODIFIED_BY="[Empty name]">
<P>The trial was powered (alpha 5% beta 80%) to detect a reduction in operative deliveries for 'fetal distress' from 50% to 40%.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-10 12:42:14 +0000" MODIFIED_BY="[Empty name]">
<P>Fetal ECG was assessed by STAN S21 machines.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-12-01 11:57:03 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Westerhuis-2010">
<CHAR_METHODS MODIFIED="2015-12-01 11:57:03 +0000" MODIFIED_BY="Heather Maxwell">
<P>A randomised clinical trial of CTG plus ST-analysis of the fetal ECG (STAN<SUP>®</SUP>) versus CTG alone for intrapartum fetal monitoring. Women randomised through a computer-generated randomisation sequence. Stratification for centre and parity (no previous vaginal delivery versus 1 or more previous vaginal deliveries). The study was performed in 9 hospitals in The Netherlands.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-03-09 12:46:09 +0000" MODIFIED_BY="[Empty name]">
<P>5681 women in labour with a singleton fetus in vertex position, a gestational age 36 weeks or greater and a medical indication for electronic fetal monitoring. A medical indication is defined by either a high-risk pregnancy, induction or augmentation of labour, epidural anaesthesia, meconium-stained amniotic fluid or non-reassuring fetal heart rate.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-06-15 12:04:03 +0100" MODIFIED_BY="Denise Atherton">
<P>Intervention group: CTG and ST-analysis. Control group: CTG.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-11-30 16:38:35 +0000" MODIFIED_BY="Heather Maxwell">
<P>Primary outcome: incidence of serious metabolic acidosis defined as a pH &lt; 7.05 and a BDecf &gt; 12 mmol/L in the umbilical cord artery.</P>
<P>Secondary outcomes:</P>
<OL>
<LI>incidence of serious metabolic acidosis defined as a pH &lt; 7.05 and a BDblood &gt; 12 mmol/L in the umbilical cord artery;</LI>
<LI>instrumental delivery rate because of fetal distress, failure to progress or a combination of the two;</LI>
<LI>neonatal outcome defined as Apgar scores &lt; 4 after 1 minute and/or &lt; 7 after 5 minutes;</LI>
<LI>need for admission to neonatal medium or intensive care unit;</LI>
<LI>incidence of performance of fetal blood sampling in both groups;</LI>
<LI>cost-effectiveness.</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-06-11 16:10:19 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-12-01 11:57:10 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Westgate-1993">
<CHAR_METHODS MODIFIED="2010-06-11 09:50:01 +0100" MODIFIED_BY="[Empty name]">
<P>Randomisation: entry to either group decided by draw of sealed, opaque envelopes once the decision to apply electrode was made.</P>
<P>Trial preceded by randomised study to identify the best available scalp electrode for ECG recording - single spiral electrode, used in both groups of the study. On ST + CTG group the lead collection system also required a maternal thigh electrode be applied to standardise the ECG vector.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-12-01 11:57:10 +0000" MODIFIED_BY="Heather Maxwell">
<P>2434 pregnant women, 1215 CTG alone arm, 1219 ST waveform and CTG arm. (More than 34 weeks' gestation with no gross fetal abnormality.)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>CTG plus ST analysis (n =1219) versus CTG alone (n = 1215).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Obstetric intervention (fetal blood sampling and operative delivery) and fetal outcome.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Operative delivery rates separated into overall caesarean section rates and operative vaginal delivery rates not recorded in published report - information to be sought from authors.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>CTG: cardiotocography<BR/>ECG: electrocardiogram<BR/>ST + CTG: ST waveform and cardiotocogram</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2015-11-30 16:40:21 +0000" MODIFIED_BY="Heather Maxwell" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2009-04-27 13:33:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hruban-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-04-27 13:33:56 +0100" MODIFIED_BY="[Empty name]">
<P>Not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-12-30 16:12:41 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ignatov-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-12-30 16:12:41 +0000" MODIFIED_BY="[Empty name]">
<P>Did not seem to involve analysis of fetal ECG waveform.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-04-27 13:34:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Janku-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-04-27 13:34:03 +0100" MODIFIED_BY="[Empty name]">
<P>Not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Olofsson-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Review article.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-11-30 16:40:21 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Prieto-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-11-30 16:40:21 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised trial reported as abstract only, with insufficient detail to include data.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>ECG: electrocardiogram</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2015-09-02 16:39:34 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2015-09-02 16:39:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gongora-2014">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES MODIFIED="2015-09-02 16:39:34 +0100" MODIFIED_BY="[Empty name]">
<P>Awaiting publication of full report. </P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2015-11-30 16:41:41 +0000" MODIFIED_BY="Heather Maxwell" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2015-01-29 12:22:02 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bach-2012">
<CHAR_STUDY_NAME MODIFIED="2015-01-29 12:21:14 +0000" MODIFIED_BY="[Empty name]">
<P>Cardiotocography combined with ST-analysis versus cardiotocography combined with scalp pH.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-01-29 12:21:36 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-01-29 12:21:42 +0000" MODIFIED_BY="[Empty name]">
<P>Women &gt; 18 years with fetus with cephalic presentation, &gt; 36 + 0 weeks, in labour, undergoing CTG monitoring.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-01-29 12:21:56 +0000" MODIFIED_BY="[Empty name]">
<P>CTG combined with ST-analysis versus cardiotocography combined with scalp pH.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-01-29 12:21:59 +0000" MODIFIED_BY="[Empty name]">
<P>Primary: metabolic acidosis at birth (umbilical artery pH &lt; 7.05 base excess &lt; -10).</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-01-29 12:22:01 +0000" MODIFIED_BY="[Empty name]">
<P>December 2005.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-01-29 12:22:02 +0000" MODIFIED_BY="[Empty name]">
<P>Diana BB Bach.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2014-12-30 16:31:13 +0000" MODIFIED_BY="[Empty name]">
<P>Trial terminated for poor recruitment 2012. Unable to obtain data so far.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-11-30 16:41:41 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Spong-2013">
<CHAR_STUDY_NAME MODIFIED="2015-01-29 12:24:19 +0000" MODIFIED_BY="[Empty name]">
<P>A randomised trial of fetal ECG ST segment and T wave analysis as an adjunct to electronic FHR monitoring (STAN).</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-11-30 16:41:41 +0000" MODIFIED_BY="Heather Maxwell">
<P>Open-randomised trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-01-29 12:23:47 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria:</P>
<UL>
<LI>Singleton, cephalic pregnancy</LI>
<LI>Gestational age at least 36 weeks, 1 day</LI>
<LI>Cervical dilation of at least 2 cm and no more than 7 cm</LI>
<LI>Ruptured membranes</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-01-29 12:24:27 +0000" MODIFIED_BY="[Empty name]">
<P>Open group: FHR monitoring with ST analysis available.<BR/>Masked group: FHR monitoring with ST analysis masked.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-01-29 12:24:30 +0000" MODIFIED_BY="[Empty name]">
<UL>
<LI>Intrapartum fetal death</LI>
<LI>Neonatal death</LI>
<LI>Apgar score &lt;= 3 at 5 minutes</LI>
<LI>Neonatal seizure</LI>
<LI>Cord artery pH &lt;= 7.05 and base deficit &gt;= 12 mmol/L</LI>
<LI>Intubation for ventilation at delivery</LI>
<LI>Presence of neonatal encephalopathy</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-01-29 12:24:37 +0000" MODIFIED_BY="[Empty name]">
<P>November 2010.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-02-14 10:45:55 +0000" MODIFIED_BY="[Empty name]">
<P>Catherine C Spong spongc@mail.nih.gov</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<FOOTNOTES>
<P>CTG: cardiotocograph<BR/>ECG: electrocardiogram<BR/>FHR: fetal heart rate<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2015-11-30 16:39:06 +0000" MODIFIED_BY="Heather Maxwell">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2015-09-24 10:23:01 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-11 10:17:17 +0000" MODIFIED_BY="Leanne V Jones" RESULT="YES" STUDY_ID="STD-Amer_x002d_Wahlin-2001">
<DESCRIPTION>
<P>&#8220;the first number available from a computer-generated table of random numbers was used to assign the women [..] according to whether the number was even or odd.&#8221; Pg 535 (Participants and methods &#8211; Methods).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-24 10:23:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Belfort-2015">
<DESCRIPTION>
<P>No explicit information about sequence generation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-11 10:11:52 +0000" MODIFIED_BY="Leanne V Jones" RESULT="YES" STUDY_ID="STD-Ojala-2006">
<DESCRIPTION>
<P>&#8220;Opaque numbered sealed envelopes that contained a randomisation code generated by a computer program in blocks of 100.&#8221; Pg 420 (Methods).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-11 10:10:43 +0000" MODIFIED_BY="Leanne V Jones" RESULT="YES" STUDY_ID="STD-Strachan-2000">
<DESCRIPTION>
<P>&#8220;Random number generation, as an integral part of the fetal ECG analyser program, was used to assign women to one of the two groups.&#8221; Pg 457 (Methods &#8211; Study design).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-29 12:16:49 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vayssiere-2007">
<DESCRIPTION>
<P>&#8220;Envelopes for randomization, stratified by center, were prepared at the Delegation of Research Unit.&#8221;</P>
<P>Insufficient information on how they achieved randomisation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-11 10:31:38 +0000" MODIFIED_BY="Leanne V Jones" RESULT="YES" STUDY_ID="STD-Westerhuis-2010">
<DESCRIPTION>
<P>Women &#8220;were randomized on a 1:1 basis through a web-based computer-generated randomization sequence with variable block size.&#8221; Pg 1174 (Materials and methods).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-29 12:19:41 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Westgate-1993">
<DESCRIPTION>
<P>"Entry to either arm was decided by draw of a sealed opaque envelope.&#8221; Pg 1152 (Study entry and randomisation).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2015-09-24 11:30:26 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-11 10:17:43 +0000" MODIFIED_BY="Leanne V Jones" RESULT="YES" STUDY_ID="STD-Amer_x002d_Wahlin-2001">
<DESCRIPTION>
<P>&#8220;Women were randomly assigned fetal monitoring [..] when STAN S21 equipment started up, the first number available from a computer-generated table of random numbers was used to assign the women [..] according to whether the number was even or odd.&#8221; Pg 535 (Participants and methods &#8211; Methods).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-24 11:30:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Belfort-2015">
<DESCRIPTION>
<P>'Once a hospital was approved to participate in the randomized trial, the independent data coordinating center sent a software card containing the encrypted randomization module to the designated local biomedical technician to be installed on the S31 monitors at that hospital'. 'A separate randomization sequence was created for each monitor'.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-11 10:12:08 +0000" MODIFIED_BY="Leanne V Jones" RESULT="YES" STUDY_ID="STD-Ojala-2006">
<DESCRIPTION>
<P>&#8220;randomly assigned to two groups using opaque numbered sealed envelopes [..] This was arranged by a person independent of the study protocol. At the time of amniotomy, the next consecutively numbered envelope available was opened by a midwife not involved in the study.&#8221; Pg 420 (Methods).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-11 10:10:24 +0000" MODIFIED_BY="Leanne V Jones" RESULT="UNKNOWN" STUDY_ID="STD-Strachan-2000">
<DESCRIPTION>
<P>&#8220;Random number generation [..] was used to assign women to one of the two groups.&#8221; Insufficient information on whether participants and enrolling investigators could foresee assignment. Pg 457 (Methods &#8211; Study design).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-29 12:17:03 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vayssiere-2007">
<DESCRIPTION>
<P>&#8220;midwife who treated the women during labor opened an opaque numbered sealed envelope at randomization.&#8221; &#8220;Envelopes for randomization, stratified by center, were prepared at the Delegation of Research Unit.&#8221; Pg 299.e2 (Materials and methods).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-29 12:18:56 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Westerhuis-2010">
<DESCRIPTION>
<P>Web-based allocation.</P>
<P>Women &#8220;were randomized on a 1:1 basis through a web-based computer-generated randomization sequence with variable block size.&#8221; Pg 1174 (Materials and methods).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-29 12:19:43 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Westgate-1993">
<DESCRIPTION>
<P>&#8220;Entry to either arm was decided by draw of a sealed opaque envelope.&#8221; Pg 1152 (Study entry and randomisation).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2014-08-19 13:50:13 +0100" MODIFIED_BY="Leanne V Jones" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2015-09-24 10:26:28 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-11-11 10:19:15 +0000" MODIFIED_BY="Leanne V Jones" RESULT="UNKNOWN" STUDY_ID="STD-Amer_x002d_Wahlin-2001">
<DESCRIPTION>
<P>&#8220;Although no electrocardiographic information was available at the time of monitoring in the CTG group, fetal electrocardiogram signals were automatically stored for both groups for future analysis.&#8221; Insufficient information. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-09-24 10:26:28 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Belfort-2015">
<DESCRIPTION>
<P>Blinding not possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-01-29 12:15:08 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ojala-2006">
<DESCRIPTION>
<P>&#8220;At the time of amniotomy, the next consecutively numbered envelope available was opened by a midwife not involved in the study.&#8221; Insufficient information on blinding of participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-11-11 10:10:08 +0000" MODIFIED_BY="Leanne V Jones" RESULT="UNKNOWN" STUDY_ID="STD-Strachan-2000">
<DESCRIPTION>
<P>&#8220;In both groups, a conventional cardiotocography was available for interpretation by the labour-ward staff.&#8221; </P>
<P>Insufficient information. Pg 457 (Methods &#8211; Study design).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-11-11 10:27:56 +0000" MODIFIED_BY="Leanne V Jones" RESULT="UNKNOWN" STUDY_ID="STD-Vayssiere-2007">
<DESCRIPTION>
<P>Insufficient information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-11-11 10:33:32 +0000" MODIFIED_BY="Leanne V Jones" RESULT="YES" STUDY_ID="STD-Westerhuis-2010">
<DESCRIPTION>
<P>"As a result of the explicit pragmatic nature of the trial, both patients and care givers were not blinded to the allocated interventions&#8221; but the outcome is not likely to be influenced by a lack of blinding. Pg 1174 (Materials and methods).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-11-11 11:03:48 +0000" MODIFIED_BY="Leanne V Jones" RESULT="UNKNOWN" STUDY_ID="STD-Westgate-1993">
<DESCRIPTION>
<P>Insufficient information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2015-11-30 16:35:32 +0000" MODIFIED_BY="Heather Maxwell" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-01-29 12:14:16 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Amer_x002d_Wahlin-2001">
<DESCRIPTION>
<P>&#8220;A paediatrician, who was unaware of which study group the neonate belonged to, assessed all paediatric files for babies admitted to the neonatal intensive-care unit, and judged whether there had been any signs of neonatal encephalopathy.&#8221; This only applies to 1 of the secondary outcomes - there is insufficient information on the blinding of other outcomes assessed. Pg 536 (Participants and methods &#8211; Methods).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-09-24 11:30:41 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Belfort-2015">
<DESCRIPTION>
<P>A protocol sub-committee that was unaware of study group assignment conducted chart of review of all cases that met criteria for primary outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-11 09:52:33 +0000" MODIFIED_BY="Leanne V Jones" RESULT="UNKNOWN" STUDY_ID="STD-Ojala-2006">
<DESCRIPTION>
<P>Insufficient information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-11 10:09:50 +0000" MODIFIED_BY="Leanne V Jones" RESULT="NO" STUDY_ID="STD-Strachan-2000">
<DESCRIPTION>
<P>&#8220;The signal was analysed with the Nottingham fetal ECG analyser; the relevant time-interval variables were displayed on-screen if the patient had been assigned to the cardiotocography plus fetal ECG group.&#8221;</P>
<P>The relevant variables show on-screen for the intervention group, therefore the outcome assessor would know that if the variables are shown then that participant is in the intervention group. Pg 457 (Methods &#8211; Study design).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-11-30 16:35:32 +0000" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Vayssiere-2007">
<DESCRIPTION>
<P>&#8220;A research resident who was not involved in the study verified data during the study.&#8221; Whilst unclear whether outcome assessors were blinded, the data were verified by someone independent of the study, therefore the outcome measurement is not likely to be influenced by lack of blinding. Pg 299.e2 (Materials and methods).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-11 10:37:18 +0000" MODIFIED_BY="Leanne V Jones" RESULT="YES" STUDY_ID="STD-Westerhuis-2010">
<DESCRIPTION>
<P>&#8220;Two neonatologists (F.G. and M.J.B.) who were blinded to randomization allocation independently assessed all neonatal admission letters and charts to evaluate whether signs of moderate or severe neonatal hypoxic&#8211;ischemic encephalopathy had developed according to Sarnat and Sarnat.&#8221; Adequate blinding for the neonatal admissions. Pg 1175 (Materials and methods).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-11 11:03:35 +0000" MODIFIED_BY="Leanne V Jones" RESULT="YES" STUDY_ID="STD-Westgate-1993">
<DESCRIPTION>
<P>&#8220;All traces were reviewed blind to outcome by a single observer [..] in 30-minute segments without preview.&#8221;</P>
<P>Although not stated if blinded for other outcomes assessed, they are not likely to be influenced by the lack of blinding. Pg 1153 (Measurement of outcome &#8211; paragraph after Neonatal outcome).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2015-11-30 16:39:06 +0000" MODIFIED_BY="Heather Maxwell" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-11 11:21:48 +0000" MODIFIED_BY="Leanne V Jones" RESULT="YES" STUDY_ID="STD-Amer_x002d_Wahlin-2001">
<DESCRIPTION>
<P>Missing data balanced in numbers across groups (283 from CTG group, 291 from CTG + ST group), with similar reasons for missing data across groups &#8220;574 cases excluded after the primary analysis..&#8221; &#8220;because of malformations or inadequate reading.&#8221; Pg 536 (Figure 2), Pg 537 (Results).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-09-24 10:30:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Belfort-2015">
<DESCRIPTION>
<P>Full clinical data, and valid umbilical blood gas results obtained from 96.5% of neonates.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-01-29 12:15:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ojala-2006">
<DESCRIPTION>
<P>&#8220;Eleven women were excluded from the outcome analysis [..] Umbilical artery blood gas analysis data were available for 1436&#8221; out of 1483 eligible.</P>
<P>Missing blood gas analysis data balanced in numbers across groups (19 from STAN group, 17 from CTG group) with the same reasons across groups. Only missing data from 36/1472 participants. Pg 420 (Results), Pg 421 (Figure 1).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-01-29 12:25:50 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Strachan-2000">
<DESCRIPTION>
<P>&#8220;Delivery details were complete for 957 (92·2%)&#8221;.</P>
<P>Of all women randomised into the trial &#8220;40 had incomplete delivery details&#8221; in both groups and 1 dropped out of the intervention group &#8220;because she didn't like the equipment in the room.&#8221; Missing outcome data balanced in numbers across both groups, but the reasons for missing data are not given, so there is insufficient information to make a judgement. Pg 457 (Flow chart of trial profile), Pg 458 (Results).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-11 10:29:22 +0000" MODIFIED_BY="Leanne V Jones" RESULT="YES" STUDY_ID="STD-Vayssiere-2007">
<DESCRIPTION>
<P>No missing outcome data &#8211; 799 women randomised after all exclusions (including 87 women who declined to participate) and were all included in the analysis. Pg 299.e3 (Results).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-11-30 16:39:06 +0000" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Westerhuis-2010">
<DESCRIPTION>
<P>No missing outcome data &#8211; 5667 randomised to the trial (after 14 women excluded as they did not meet the inclusion criteria) and were included in the analysis - intention-to-treat analysis.</P>
<P>&#8220;Various subjects had missing values. Because these are often selectively missing, which was also the case in our study [..] it is well documented that a complete case analysis likely yields biased results. Hence, we multiply imputed missing values (10 times) before doing the analysis, using the AregImpute method in S-plus.&#8221;</P>
<P>They have adopted an appropriate method for overcoming any impact, from missing values, on the risk of bias. Pg 1176 (Materials and methods). Pg 1176 (Materials and methods), Pg 1176 (Results, Fig. 1).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-11 11:53:50 +0000" MODIFIED_BY="Leanne V Jones" RESULT="YES" STUDY_ID="STD-Westgate-1993">
<DESCRIPTION>
<P>&#8220;Three cases of noncompliance in the cardiotocogram arm. In two a recording was unobtainable [..] In the third there were no cardiotocogram recorders available.&#8221; &#8220;There were 31 cases in the ST waveform plus cardiotocogram arm. Ten of these were protocol failure and four were technical failures [..] In 17 cases no satisfactory heart rate or electrocardiographic trace could be obtained..&#8221; An imbalance in numbers of missing data across the groups (3 from control, 31 from intervention), but overall only 34/2434 cases and the reasons for missing data are all unrelated to the true outcome. Pg 1154 (Results - Noncompliance with allocated recorder).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2015-09-24 10:30:18 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-29 12:17:47 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Amer_x002d_Wahlin-2001">
<DESCRIPTION>
<P>Study protocol not available but all of the study&#8217;s expected (primary and secondary) outcomes that are of interest/pre-specified in the methods section have been reported in the results/tables, whether significant or not.</P>
<P>&#8220;The rate of metabolic acidosis at birth was significantly lower in the CTG+ST group than in the CTG group. The number of operative deliveries for fetal distress was also significantly lower in the CTG + ST group. The rates of operative deliveries for other indications (in most cases failure to progress) did not differ significantly. Pg 536 (Results), Pg 537 (Table 3).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-24 10:30:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Belfort-2015">
<DESCRIPTION>
<P>No evidence of selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-29 12:15:38 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ojala-2006">
<DESCRIPTION>
<P>Study protocol is not available but all of the study&#8217;s expected (primary and secondary) outcomes that are of interest/pre-specified in the methods section have been reported in the results/tables, whether significant or not.</P>
<P>Pg 420 (Results), Pg 422 (Table 2), Pg 422 (Table 3).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-29 12:18:01 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Strachan-2000">
<DESCRIPTION>
<P>Study protocol is not available but all the study&#8217;s expected outcomes that are of interest/pre-specified in the methods section have been reported in the results/tables, whether significant or not. Pg 458 (Results, Table 2, Table 3, Table 4).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-29 12:17:32 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vayssiere-2007">
<DESCRIPTION>
<P>Study protocol is not available but all of the study&#8217;s expected (primary and secondary) outcomes that are of interest/pre-specified in the methods section have been reported in the results/tables, whether significant or not. Pg 299.e3 (Results, Table 2). Pg 299.e5 (Table 3).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-29 12:18:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Westerhuis-2010">
<DESCRIPTION>
<P>Study protocol is not available but all of the study&#8217;s expected (primary and secondary) outcomes that are of interest/pre-specified in the methods section have been reported in the results/tables, whether significant or not.</P>
<P>Pg 1176 - 1177 (Results), Pg 1177 (Table 2), Pg 1178 (Table 3).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-11 11:06:24 +0000" MODIFIED_BY="Leanne V Jones" RESULT="UNKNOWN" STUDY_ID="STD-Westgate-1993">
<DESCRIPTION>
<P>Insufficient information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2015-09-23 18:15:35 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-11 11:22:12 +0000" MODIFIED_BY="Leanne V Jones" RESULT="YES" STUDY_ID="STD-Amer_x002d_Wahlin-2001">
<DESCRIPTION>
<P>Appears to be free of other sources of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-23 18:15:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Belfort-2015">
<DESCRIPTION>
<P>The study was supported by a government health research funder (NICHD) and by the manufacturer of the equipment (Neoventa). Neoventa had, it is stated, no role in monitoring the study, data collection and analysis, or manuscript preparation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-11 09:54:23 +0000" MODIFIED_BY="Leanne V Jones" RESULT="YES" STUDY_ID="STD-Ojala-2006">
<DESCRIPTION>
<P>The study appears to be free of other sources of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-11 10:08:47 +0000" MODIFIED_BY="Leanne V Jones" RESULT="UNKNOWN" STUDY_ID="STD-Strachan-2000">
<DESCRIPTION>
<P>&#8220;Both problems with signal acquisition and failure to act on abnormal readings within the acidaemic group suggest that there may have been protocol violation within the trial group as a whole.&#8221; Pg 459 (Discussion).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-11 10:30:23 +0000" MODIFIED_BY="Leanne V Jones" RESULT="UNKNOWN" STUDY_ID="STD-Vayssiere-2007">
<DESCRIPTION>
<P>Insufficient information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-11 10:42:40 +0000" MODIFIED_BY="Leanne V Jones" RESULT="YES" STUDY_ID="STD-Westerhuis-2010">
<DESCRIPTION>
<P>Appears to be free of other sources of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-11 11:06:41 +0000" MODIFIED_BY="Leanne V Jones" RESULT="YES" STUDY_ID="STD-Westgate-1993">
<DESCRIPTION>
<P>Appears to be free of other sources of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2015-12-01 12:00:58 +0000" MODIFIED_BY="Heather Maxwell">
<SOF_TABLE ID="SOF-01" MODIFIED="2015-12-01 12:00:58 +0000" MODIFIED_BY="Heather Maxwell" NO="1" READONLY="YES">
<TITLE MODIFIED="2015-12-01 12:00:58 +0000" MODIFIED_BY="Heather Maxwell">Fetal electrocardiogram (ECG) (ST analysis) plus cardiotocography (CTG) versus CTG alone for fetal monitoring during labour</TITLE>
<TABLE COLS="7" ROWS="34">
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Fetal ECG (ST analysis) plus CTG versus CTG alone for fetal monitoring during labour</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Patient or population: </B>Pregnant women (and their fetuses) in labour, with a perceived need for continuous electronic fetal heart rate monitoring<BR/>
<B>Settings: </B>Sweden, USA, Finland, France, The Netherlands, UK.<BR/>
<B>Intervention: </B>Fetal ECG (ST analysis) plus CTG<BR/>
<B>Comparison: </B>CTG alone</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Anticipated absolute effects<SUP>*</SUP> (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8470; of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with CTG alone</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with Fetal ECG plus CTG</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>Caesarean section - ST analysis</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>RR 1.02<BR/>(0.96 to 1.08)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>26,446<BR/>(6 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>135 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>137 per 1000<BR/>(129 to 145)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>119 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>121 per 1000<BR/>(114 to 128)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>Cord pH less than 7.05 and base deficit greater than 12 mmol/L - ST analysis</P>
<P/>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.72<BR/>(0.43 to 1.20)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>25,682<BR/>(6 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>9 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>7 per 1000<BR/>(4 to 11)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>11 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>8 per 1000<BR/>(5 to 13)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>Neonatal encephalopathy - ST analysis</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.61<BR/>(0.30 to 1.22)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>26,410<BR/>(6 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>2 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>1 per 1000<BR/>(0 to 2)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>2 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>1 per 1000<BR/>(1 to 2)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>Fetal blood sampling - ST analysis</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.61<BR/>(0.41 to 0.91)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>9671<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>154 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>94 per 1000<BR/>(63 to 140)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>131 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>80 per 1000<BR/>(54 to 119)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>Operative vaginal delivery - ST analysis</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.92<BR/>(0.86 to 0.99)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>26,446<BR/>(6 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>113 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>104 per 1000<BR/>(97 to 112)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>133 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>122 per 1000<BR/>(114 to 131)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>Admission to neonatal special care unit - ST analysis</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.96<BR/>(0.89 to 1.04)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>26410<BR/>(6 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>88 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>84 per 1000<BR/>(78 to 91)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>55 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>53 per 1000<BR/>(49 to 57)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>Perinatal death - ST analysis</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>RR 1.71<BR/>(0.67 to 4.33)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>26,446<BR/>(6 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>0 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>1 per 1000<BR/>(0 to 2)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>0 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>1 per 1000<BR/>(0 to 2)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Some heterogeneity in findings (I<SUP>2</SUP> 55%)</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2015-12-21 12:52:41 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2015-12-21 12:52:41 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Fetal ECG plus CTG versus CTG alone</NAME>
<DICH_OUTCOME CHI2="7.811394734971195" CI_END="1.0684067814778064" CI_START="0.9497340700449081" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0073243375579177" ESTIMABLE="YES" EVENTS_1="1889" EVENTS_2="1877" I2="23.18913326530124" I2_Q="68.36697849351589" ID="CMP-001.01" LOG_CI_END="0.02873663594709224" LOG_CI_START="-0.02239798216346427" LOG_EFFECT_SIZE="0.003169326891813981" METHOD="MH" MODIFIED="2015-09-24 11:12:08 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2522494444968312" P_Q="0.07540559611851239" P_Z="0.8080384100625563" Q="3.161253501487427" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="13711" TOTAL_2="13692" WEIGHT="200.0" Z="0.24295738553319843">
<NAME>Caesarean section</NAME>
<GROUP_LABEL_1>ECG</GROUP_LABEL_1>
<GROUP_LABEL_2>No ECG</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ECG analysis</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.658569289227983" CI_END="1.0825644745695893" CI_START="0.9594455067607371" DF="5" EFFECT_SIZE="1.01914749712914" ESTIMABLE="YES" EVENTS_1="1810" EVENTS_2="1779" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="0.034453771183323864" LOG_CI_START="-0.017979686676479964" LOG_EFFECT_SIZE="0.008237042253421936" MODIFIED="2015-09-24 10:38:28 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.45895172354696734" P_Z="0.5380254108931553" STUDIES="6" TAU2="0.0" TOTAL_1="13229" TOTAL_2="13217" WEIGHT="100.0" Z="0.6158016966574343">
<NAME>ST analysis</NAME>
<DICH_DATA CI_END="1.1004433402668643" CI_START="0.7673200701110852" EFFECT_SIZE="0.9189081896505478" ESTIMABLE="YES" EVENTS_1="210" EVENTS_2="222" LOG_CI_END="0.041567686468721506" LOG_CI_START="-0.11502344219480788" LOG_EFFECT_SIZE="-0.03672787786304319" ORDER="52827" O_E="0.0" SE="0.09198240411554533" STUDY_ID="STD-Amer_x002d_Wahlin-2001" TOTAL_1="2519" TOTAL_2="2447" VAR="0.008460762666875489" WEIGHT="12.669301075982537"/>
<DICH_DATA CI_END="1.1360057240046653" CI_START="0.9610474664436014" EFFECT_SIZE="1.0448710077900107" ESTIMABLE="YES" EVENTS_1="934" EVENTS_2="901" LOG_CI_END="0.05538051966494516" LOG_CI_START="-0.017255161857524366" LOG_EFFECT_SIZE="0.019062678903710405" MODIFIED="2015-09-24 10:38:28 +0100" MODIFIED_BY="[Empty name]" ORDER="47" O_E="0.0" SE="0.04266655887872094" STUDY_ID="STD-Belfort-2015" TOTAL_1="5532" TOTAL_2="5576" VAR="0.0018204352465513605" WEIGHT="50.48348428481974"/>
<DICH_DATA CI_END="2.0718702777667595" CI_START="0.8846632661389097" EFFECT_SIZE="1.3538491522120444" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="35" LOG_CI_END="0.31636256023645654" LOG_CI_START="-0.05322200555817729" LOG_EFFECT_SIZE="0.13157027733913962" ORDER="52829" O_E="0.0" SE="0.21709580342087392" STUDY_ID="STD-Ojala-2006" TOTAL_1="733" TOTAL_2="739" VAR="0.04713058786295474" WEIGHT="1.9608412709900456"/>
<DICH_DATA CI_END="1.1507328275610549" CI_START="0.7204719579718084" EFFECT_SIZE="0.9105332137683658" ESTIMABLE="YES" EVENTS_1="99" EVENTS_2="109" LOG_CI_END="0.06097450261782878" LOG_CI_START="-0.14238291802154793" LOG_EFFECT_SIZE="-0.040704207701859584" MODIFIED="2008-11-18 14:51:35 +0000" MODIFIED_BY="[Empty name]" ORDER="50" O_E="0.0" SE="0.11945315551903686" STUDY_ID="STD-Vayssiere-2007" TOTAL_1="399" TOTAL_2="400" VAR="0.014269056363455207" WEIGHT="6.123938836958619"/>
<DICH_DATA CI_END="1.1836488620105852" CI_START="0.9147843156785453" EFFECT_SIZE="1.0405687936114758" ESTIMABLE="YES" EVENTS_1="405" EVENTS_2="391" LOG_CI_END="0.07322288489647462" LOG_CI_START="-0.03868129014383489" LOG_EFFECT_SIZE="0.01727079737631987" MODIFIED="2010-06-11 17:06:16 +0100" MODIFIED_BY="[Empty name]" ORDER="52" O_E="0.0" SE="0.06573306635327798" STUDY_ID="STD-Westerhuis-2010" TOTAL_1="2827" TOTAL_2="2840" VAR="0.004320836012204446" WEIGHT="21.944595674312982"/>
<DICH_DATA CI_END="1.207342226894117" CI_START="0.7432581744372209" EFFECT_SIZE="0.9472945579292062" ESTIMABLE="YES" EVENTS_1="115" EVENTS_2="121" LOG_CI_END="0.08183039038329186" LOG_CI_START="-0.12886030567707057" LOG_EFFECT_SIZE="-0.023514957646889354" ORDER="52828" O_E="0.0" SE="0.12376075780162267" STUDY_ID="STD-Westgate-1993" TOTAL_1="1219" TOTAL_2="1215" VAR="0.015316725171631906" WEIGHT="6.817838856936077"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.038467060892436" CI_START="0.6077184874490483" DF="0" EFFECT_SIZE="0.7944152764840376" ESTIMABLE="YES" EVENTS_1="79" EVENTS_2="98" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="0.01639272571509892" LOG_CI_START="-0.21629755174717175" LOG_EFFECT_SIZE="-0.09995241301603641" NO="2" P_CHI2="1.0" P_Z="0.0922183580469289" STUDIES="1" TAU2="0.0" TOTAL_1="482" TOTAL_2="475" WEIGHT="100.00000000000001" Z="1.6838101859332602">
<NAME>PR analysis</NAME>
<DICH_DATA CI_END="1.0384670608924358" CI_START="0.6077184874490484" EFFECT_SIZE="0.7944152764840376" ESTIMABLE="YES" EVENTS_1="79" EVENTS_2="98" LOG_CI_END="0.016392725715098828" LOG_CI_START="-0.21629755174717166" LOG_EFFECT_SIZE="-0.09995241301603641" ORDER="52830" O_E="0.0" SE="0.13668342081678775" STUDY_ID="STD-Strachan-2000" TOTAL_1="482" TOTAL_2="475" VAR="0.01868235752617909" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="11.141638486333601" CI_END="1.1968620819550118" CI_START="0.42949363925680184" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7169690727411683" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="121" I2="55.123297115293866" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.07804410822026214" LOG_CI_START="-0.36704326362814593" LOG_EFFECT_SIZE="-0.14449957770394187" METHOD="MH" MODIFIED="2015-09-24 11:13:24 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.04864297129212347" P_Q="1.0" P_Z="0.20315226946221265" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.2066176868008264" TOTALS="SUB" TOTAL_1="12850" TOTAL_2="12832" WEIGHT="100.0" Z="1.272621898504156">
<NAME>Cord pH &lt; 7.05 + base deficit &gt; 12 mmol/L</NAME>
<GROUP_LABEL_1>ECG</GROUP_LABEL_1>
<GROUP_LABEL_2>No ECG</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ECG analysis</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="11.141638486333601" CI_END="1.1968620819550118" CI_START="0.42949363925680184" DF="5" EFFECT_SIZE="0.7169690727411683" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="121" I2="55.123297115293866" ID="CMP-001.02.01" LOG_CI_END="0.07804410822026214" LOG_CI_START="-0.36704326362814593" LOG_EFFECT_SIZE="-0.14449957770394187" MODIFIED="2015-09-24 10:42:33 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.04864297129212347" P_Z="0.20315226946221265" STUDIES="6" TAU2="0.2066176868008264" TOTAL_1="12850" TOTAL_2="12832" WEIGHT="100.0" Z="1.272621898504156">
<NAME>ST analysis</NAME>
<DICH_DATA CI_END="0.9602367107316088" CI_START="0.24141563722065915" EFFECT_SIZE="0.48147290412227883" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="24" LOG_CI_END="-0.017621694572437792" LOG_CI_START="-0.6172346027610479" LOG_EFFECT_SIZE="-0.3174281486667428" MODIFIED="2011-05-19 14:57:22 +0100" MODIFIED_BY="[Empty name]" ORDER="52813" O_E="0.0" SE="0.3522155904017545" STUDY_ID="STD-Amer_x002d_Wahlin-2001" TOTAL_1="2159" TOTAL_2="2079" VAR="0.12405582212205649" WEIGHT="20.671231235980148"/>
<DICH_DATA CI_END="1.4240052926057887" CI_START="0.10033030195684901" EFFECT_SIZE="0.3779826464208243" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="8" LOG_CI_END="0.15351160344775988" LOG_CI_START="-0.998567880686962" LOG_EFFECT_SIZE="-0.4225281386196011" MODIFIED="2015-09-24 10:42:33 +0100" MODIFIED_BY="[Empty name]" ORDER="48" O_E="0.0" SE="0.6767371918661571" STUDY_ID="STD-Belfort-2015" TOTAL_1="5532" TOTAL_2="5576" VAR="0.457973226854892" WEIGHT="10.28516704954358"/>
<DICH_DATA CI_END="6.853368402861088" CI_START="0.8594020336872299" EFFECT_SIZE="2.426890756302521" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="5" LOG_CI_END="0.8359040779474597" LOG_CI_START="-0.06580362293731827" LOG_EFFECT_SIZE="0.38505022750507073" ORDER="52815" O_E="0.0" SE="0.5296675670248248" STUDY_ID="STD-Ojala-2006" TOTAL_1="714" TOTAL_2="722" VAR="0.28054773155799717" WEIGHT="14.031021720682146"/>
<DICH_DATA CI_END="4.86087743783324" CI_START="0.5292970648625044" EFFECT_SIZE="1.6040100250626566" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.6867146709112518" LOG_CI_START="-0.27630051431697383" LOG_EFFECT_SIZE="0.2052070782971389" MODIFIED="2008-11-10 17:00:40 +0000" MODIFIED_BY="[Empty name]" ORDER="45" O_E="0.0" SE="0.5656798868051078" STUDY_ID="STD-Vayssiere-2007" TOTAL_1="399" TOTAL_2="400" VAR="0.3199937343358396" WEIGHT="12.980023395246356"/>
<DICH_DATA CI_END="0.9182845829884384" CI_START="0.42411888641119727" EFFECT_SIZE="0.6240687740510874" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="66" LOG_CI_END="-0.037022706959550504" LOG_CI_START="-0.37251238756967975" LOG_EFFECT_SIZE="-0.20476754726461513" MODIFIED="2011-01-26 17:35:44 +0000" MODIFIED_BY="[Empty name]" ORDER="53" O_E="0.0" SE="0.19706829909109239" STUDY_ID="STD-Westerhuis-2010" TOTAL_1="2827" TOTAL_2="2840" VAR="0.038835914506656244" WEIGHT="27.848149426803616"/>
<DICH_DATA CI_END="1.0720129029625065" CI_START="0.13708768294419907" EFFECT_SIZE="0.3833533160850634" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.030200012643778366" LOG_CI_START="-0.8630015639535162" LOG_EFFECT_SIZE="-0.41640077565486894" ORDER="52814" O_E="0.0" SE="0.5246710275123627" STUDY_ID="STD-Westgate-1993" TOTAL_1="1219" TOTAL_2="1215" VAR="0.27527968711087847" WEIGHT="14.184407171744148"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>PR analysis</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.5672829176249037" CI_END="1.2229274024524899" CI_START="0.3004637141756243" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.606172673013246" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="20" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.08740067645566725" LOG_CI_START="-0.5222079685358493" LOG_EFFECT_SIZE="-0.217403646040091" METHOD="MH" MODIFIED="2015-09-24 11:14:36 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.6132323737527139" P_Q="1.0" P_Z="0.16212599984340512" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="13210" TOTAL_2="13200" WEIGHT="100.0" Z="1.3979569346566667">
<NAME>Neonatal encephalopathy</NAME>
<GROUP_LABEL_1>ECG</GROUP_LABEL_1>
<GROUP_LABEL_2>No ECG</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ECG analysis</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.5672829176249037" CI_END="1.2229274024524899" CI_START="0.3004637141756243" DF="5" EFFECT_SIZE="0.606172673013246" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="20" I2="0.0" ID="CMP-001.03.01" LOG_CI_END="0.08740067645566725" LOG_CI_START="-0.5222079685358493" LOG_EFFECT_SIZE="-0.217403646040091" MODIFIED="2015-09-24 10:47:09 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6132323737527139" P_Z="0.16212599984340512" STUDIES="6" TAU2="0.0" TOTAL_1="13210" TOTAL_2="13200" WEIGHT="100.0" Z="1.3979569346566667">
<NAME>ST analysis</NAME>
<DICH_DATA CI_END="1.3715023080216198" CI_START="0.09675593105257307" EFFECT_SIZE="0.36428146089718144" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="8" LOG_CI_END="0.1371965427901364" LOG_CI_START="-1.0143224036273466" LOG_EFFECT_SIZE="-0.43856293041860495" ORDER="52806" O_E="0.0" SE="0.6764079292363444" STUDY_ID="STD-Amer_x002d_Wahlin-2001" TOTAL_1="2519" TOTAL_2="2447" VAR="0.45752768673379957" WEIGHT="39.41547978280304"/>
<DICH_DATA CI_END="3.001272438300378" CI_START="0.2166485273559896" EFFECT_SIZE="0.8063629790310918" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.47730541997674053" LOG_CI_START="-0.6642442586874933" LOG_EFFECT_SIZE="-0.0934694193553764" MODIFIED="2015-09-24 10:47:09 +0100" MODIFIED_BY="[Empty name]" ORDER="49" O_E="0.0" SE="0.6705519320094147" STUDY_ID="STD-Belfort-2015" TOTAL_1="5532" TOTAL_2="5576" VAR="0.4496398935215587" WEIGHT="24.18642515725785"/>
<DICH_DATA CI_END="8.260229619344017" CI_START="0.013754027282175712" EFFECT_SIZE="0.33706293706293705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9169921200840603" LOG_CI_START="-1.8615701185364846" LOG_EFFECT_SIZE="-0.47228899922621226" ORDER="52808" O_E="0.0" SE="1.6321412130706128" STUDY_ID="STD-Ojala-2006" TOTAL_1="714" TOTAL_2="722" VAR="2.6638849394036113" WEIGHT="7.244256062306215"/>
<DICH_DATA CI_END="15.972036970830374" CI_START="0.06292364677914027" EFFECT_SIZE="1.0025062656641603" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2033603067945915" LOG_CI_START="-1.2011861155121633" LOG_EFFECT_SIZE="0.0010870956412141369" MODIFIED="2008-11-10 16:58:03 +0000" MODIFIED_BY="[Empty name]" ORDER="43" O_E="0.0" SE="1.4124424711597423" STUDY_ID="STD-Vayssiere-2007" TOTAL_1="399" TOTAL_2="400" VAR="1.9949937343358397" WEIGHT="4.850443995344925"/>
<DICH_DATA CI_END="28.95586019597034" CI_START="0.3136830856829678" EFFECT_SIZE="3.0137955429784222" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4617364711106722" LOG_CI_START="-0.5035088985563112" LOG_EFFECT_SIZE="0.47911378627718054" MODIFIED="2010-06-11 17:12:14 +0100" MODIFIED_BY="[Empty name]" ORDER="54" O_E="0.0" SE="1.154394858263859" STUDY_ID="STD-Westerhuis-2010" TOTAL_1="2827" TOTAL_2="2840" VAR="1.3326274887860352" WEIGHT="4.84538146791774"/>
<DICH_DATA CI_END="2.226173683272431" CI_START="0.02789113048966865" EFFECT_SIZE="0.24917965545529122" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3475590444300796" LOG_CI_START="-1.5545338824541062" LOG_EFFECT_SIZE="-0.6034874190120133" ORDER="52807" O_E="0.0" SE="1.1172988007636102" STUDY_ID="STD-Westgate-1993" TOTAL_1="1219" TOTAL_2="1215" VAR="1.2483566101878014" WEIGHT="19.458013534370217"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>PR analysis</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="44.958686551073555" CI_END="0.9996813100136831" CI_START="0.6374396581335358" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7982709518062192" ESTIMABLE="YES" EVENTS_1="567" EVENTS_2="826" I2="91.10294293082616" I2_Q="61.102298792757395" ID="CMP-001.04" LOG_CI_END="-1.3842736137398542E-4" LOG_CI_START="-0.1955609205096436" LOG_EFFECT_SIZE="-0.09784967393550886" METHOD="MH" MODIFIED="2015-12-21 12:52:02 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="4.055402458291724E-9" P_Q="0.10884986985377076" P_Z="0.049676315744600824" Q="2.5708460113673857" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.13501752994294453" TOTALS="SUB" TOTAL_1="5352" TOTAL_2="5276" WEIGHT="200.0" Z="1.9627406622745065">
<NAME>Fetal blood sampling</NAME>
<GROUP_LABEL_1>ECG</GROUP_LABEL_1>
<GROUP_LABEL_2>No ECG</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ECG analysis</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="39.16747909957123" CI_END="0.9085502811102526" CI_START="0.4127551207417408" DF="3" EFFECT_SIZE="0.6123796052936485" ESTIMABLE="YES" EVENTS_1="486" EVENTS_2="738" I2="92.34058441092564" ID="CMP-001.04.01" LOG_CI_END="-0.0416510329079912" LOG_CI_START="-0.38430753006738305" LOG_EFFECT_SIZE="-0.2129792814876872" MODIFIED="2008-11-10 17:05:41 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.5995112456757E-8" P_Z="0.01483245683239467" STUDIES="4" TAU2="0.1476287896876388" TOTAL_1="4870" TOTAL_2="4801" WEIGHT="100.00000000000001" Z="2.4364442211344404">
<NAME>ST analysis</NAME>
<DICH_DATA CI_END="1.0296846383159284" CI_START="0.7366447028508347" EFFECT_SIZE="0.8709257915702728" ESTIMABLE="YES" EVENTS_1="234" EVENTS_2="261" LOG_CI_END="0.012704233627102834" LOG_CI_START="-0.13274192977602678" LOG_EFFECT_SIZE="-0.060018848074461964" ORDER="52839" O_E="0.0" SE="0.0854357963531187" STUDY_ID="STD-Amer_x002d_Wahlin-2001" TOTAL_1="2519" TOTAL_2="2447" VAR="0.00729927529849157" WEIGHT="26.149479530649536"/>
<DICH_DATA CI_END="0.6117415200136498" CI_START="0.32678163482871697" EFFECT_SIZE="0.44710836941692866" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="115" LOG_CI_END="-0.21343204214258765" LOG_CI_START="-0.48574235886136735" LOG_EFFECT_SIZE="-0.3495872005019775" ORDER="52841" O_E="0.0" SE="0.15995642799841855" STUDY_ID="STD-Ojala-2006" TOTAL_1="733" TOTAL_2="739" VAR="0.025586058858013263" WEIGHT="23.38880470175286"/>
<DICH_DATA CI_END="0.5218412344930742" CI_START="0.3652413570266996" EFFECT_SIZE="0.43657530924084403" ESTIMABLE="YES" EVENTS_1="108" EVENTS_2="248" LOG_CI_END="-0.28246160709614687" LOG_CI_START="-0.437420052299958" LOG_EFFECT_SIZE="-0.3599408296980524" MODIFIED="2008-11-10 17:05:41 +0000" MODIFIED_BY="[Empty name]" ORDER="49" O_E="0.0" SE="0.09102335776939338" STUDY_ID="STD-Vayssiere-2007" TOTAL_1="399" TOTAL_2="400" VAR="0.008285251659614986" WEIGHT="25.98411425341015"/>
<DICH_DATA CI_END="1.0567541059600642" CI_START="0.6256441601212734" EFFECT_SIZE="0.8131125599067398" ESTIMABLE="YES" EVENTS_1="93" EVENTS_2="114" LOG_CI_END="0.023973943931701904" LOG_CI_START="-0.20367260486487865" LOG_EFFECT_SIZE="-0.0898493304665884" ORDER="52840" O_E="0.0" SE="0.13372070963170185" STUDY_ID="STD-Westgate-1993" TOTAL_1="1219" TOTAL_2="1215" VAR="0.017881228184405924" WEIGHT="24.477601514187466"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1928949629354242" CI_START="0.6897562294925628" DF="0" EFFECT_SIZE="0.9070869483213881" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="88" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="0.0766022047551518" LOG_CI_START="-0.16130436852615562" LOG_EFFECT_SIZE="-0.04235108188550189" NO="2" P_CHI2="1.0" P_Z="0.48529706910223813" STUDIES="1" TAU2="0.0" TOTAL_1="482" TOTAL_2="475" WEIGHT="100.0" Z="0.6978083375925985">
<NAME>PR analysis</NAME>
<DICH_DATA CI_END="1.1928949629354242" CI_START="0.6897562294925628" EFFECT_SIZE="0.9070869483213881" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="88" LOG_CI_END="0.0766022047551518" LOG_CI_START="-0.16130436852615562" LOG_EFFECT_SIZE="-0.04235108188550189" ORDER="52842" O_E="0.0" SE="0.1397474988019707" STUDY_ID="STD-Strachan-2000" TOTAL_1="482" TOTAL_2="475" VAR="0.019529363421406806" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.532569493205878" CI_END="0.9834820077979786" CI_START="0.863324626703275" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9214468173755755" ESTIMABLE="YES" EVENTS_1="1489" EVENTS_2="1611" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-0.007233580823983722" LOG_CI_START="-0.06382587047677796" LOG_EFFECT_SIZE="-0.03552972565038084" METHOD="MH" MODIFIED="2015-12-21 12:52:02 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.6049987659406111" P_Q="0.8774617457914731" P_Z="0.013854804275618356" Q="0.023773850742831358" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="13711" TOTAL_2="13692" WEIGHT="200.0" Z="2.4610060162814826">
<NAME>Operative vaginal delivery</NAME>
<GROUP_LABEL_1>ECG</GROUP_LABEL_1>
<GROUP_LABEL_2>No ECG</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ECG analysis</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.509056709182361" CI_END="0.98506191642753" CI_START="0.8595411724446" DF="5" EFFECT_SIZE="0.9201637216151503" ESTIMABLE="YES" EVENTS_1="1373" EVENTS_2="1489" I2="0.0" ID="CMP-001.05.01" LOG_CI_END="-0.006536470905729866" LOG_CI_START="-0.06573331555955134" LOG_EFFECT_SIZE="-0.03613489323264062" MODIFIED="2015-09-24 12:30:00 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.47867264492992034" P_Z="0.016720376670622494" STUDIES="6" TAU2="0.0" TOTAL_1="13229" TOTAL_2="13217" WEIGHT="100.0" Z="2.3927994721794263">
<NAME>ST analysis</NAME>
<DICH_DATA CI_END="1.0032400215626434" CI_START="0.7245974739788629" EFFECT_SIZE="0.8526108053612688" ESTIMABLE="YES" EVENTS_1="244" EVENTS_2="278" LOG_CI_END="0.0014048488426236278" LOG_CI_START="-0.13990318429396503" LOG_EFFECT_SIZE="-0.06924916772567069" ORDER="52831" O_E="0.0" SE="0.08300503815047737" STUDY_ID="STD-Amer_x002d_Wahlin-2001" TOTAL_1="2519" TOTAL_2="2447" VAR="0.006889836358362203" WEIGHT="18.919150084037916"/>
<DICH_DATA CI_END="1.1764247646100912" CI_START="0.8742050677020876" EFFECT_SIZE="1.0141185783686133" ESTIMABLE="YES" EVENTS_1="329" EVENTS_2="327" LOG_CI_END="0.07056415815083122" LOG_CI_START="-0.05838668026609465" LOG_EFFECT_SIZE="0.006088738942368303" MODIFIED="2015-09-24 10:50:57 +0100" MODIFIED_BY="[Empty name]" ORDER="50" O_E="0.0" SE="0.07574636080304707" STUDY_ID="STD-Belfort-2015" TOTAL_1="5532" TOTAL_2="5576" VAR="0.005737511174905387" WEIGHT="21.848892468847588"/>
<DICH_DATA CI_END="1.2119921109466503" CI_START="0.6584503487202631" EFFECT_SIZE="0.8933289585024263" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="79" LOG_CI_END="0.08349979294620143" LOG_CI_START="-0.18147696799117505" LOG_EFFECT_SIZE="-0.04898858752248679" ORDER="52833" O_E="0.0" SE="0.1556486610307357" STUDY_ID="STD-Ojala-2006" TOTAL_1="733" TOTAL_2="739" VAR="0.02422650568066087" WEIGHT="5.277869286991706"/>
<DICH_DATA CI_END="1.303482718604464" CI_START="0.8414040375947643" EFFECT_SIZE="1.0472610096670247" ESTIMABLE="YES" EVENTS_1="117" EVENTS_2="112" LOG_CI_END="0.11510527772569622" LOG_CI_START="-0.07499540829130782" LOG_EFFECT_SIZE="0.020054934717194207" MODIFIED="2008-11-18 14:52:47 +0000" MODIFIED_BY="[Empty name]" ORDER="51" O_E="0.0" SE="0.11166608397996043" STUDY_ID="STD-Vayssiere-2007" TOTAL_1="399" TOTAL_2="400" VAR="0.012469314311419575" WEIGHT="7.503769989355416"/>
<DICH_DATA CI_END="1.016557760828348" CI_START="0.7880629521299316" EFFECT_SIZE="0.895048328309137" ESTIMABLE="YES" EVENTS_1="384" EVENTS_2="431" LOG_CI_END="0.0071320602946055855" LOG_CI_START="-0.10343908876597091" LOG_EFFECT_SIZE="-0.04815351423568269" MODIFIED="2015-09-24 12:30:00 +0100" MODIFIED_BY="[Empty name]" ORDER="54" O_E="0.0" SE="0.06495004029419779" STUDY_ID="STD-Westerhuis-2010" TOTAL_1="2827" TOTAL_2="2840" VAR="0.004218507734217916" WEIGHT="28.845976160046106"/>
<DICH_DATA CI_END="1.0208097215133947" CI_START="0.7434790397410733" EFFECT_SIZE="0.8711777267062853" ESTIMABLE="YES" EVENTS_1="229" EVENTS_2="262" LOG_CI_END="0.008944797328810485" LOG_CI_START="-0.12873127065662732" LOG_EFFECT_SIZE="-0.05989323666390839" ORDER="52832" O_E="0.0" SE="0.0808716038421739" STUDY_ID="STD-Westgate-1993" TOTAL_1="1219" TOTAL_2="1215" VAR="0.006540216308005517" WEIGHT="17.604342010721272"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1679756498288008" CI_START="0.7517192490836865" DF="0" EFFECT_SIZE="0.9370110876811101" ESTIMABLE="YES" EVENTS_1="116" EVENTS_2="122" I2="0.0" ID="CMP-001.05.02" LOG_CI_END="0.0674337886195136" LOG_CI_START="-0.12394432874313922" LOG_EFFECT_SIZE="-0.028255270061812783" NO="2" P_CHI2="1.0" P_Z="0.5627630314513888" STUDIES="1" TAU2="0.0" TOTAL_1="482" TOTAL_2="475" WEIGHT="100.0" Z="0.5787423604932282">
<NAME>PR analysis</NAME>
<DICH_DATA CI_END="1.1679756498288008" CI_START="0.7517192490836865" EFFECT_SIZE="0.9370110876811101" ESTIMABLE="YES" EVENTS_1="116" EVENTS_2="122" LOG_CI_END="0.0674337886195136" LOG_CI_START="-0.12394432874313922" LOG_EFFECT_SIZE="-0.028255270061812783" ORDER="52834" O_E="0.0" SE="0.11241645347578168" STUDY_ID="STD-Strachan-2000" TOTAL_1="482" TOTAL_2="475" VAR="0.012637459012072588" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.1217300231979" CI_END="1.1906824104134701" CI_START="0.7051442672298249" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9162984643632489" ESTIMABLE="YES" EVENTS_1="106" EVENTS_2="115" I2="2.376736427858302" I2_Q="25.025540429349714" ID="CMP-001.06" LOG_CI_END="0.07579593797486199" LOG_CI_START="-0.1517220205233832" LOG_EFFECT_SIZE="-0.03796304127426059" METHOD="MH" MODIFIED="2015-12-21 12:52:02 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.4012058201891947" P_Q="0.2481326743993727" P_Z="0.513067516036996" Q="1.3337875400858012" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="8160" TOTAL_2="8099" WEIGHT="200.0" Z="0.6540687524825186">
<NAME>Apgar score &lt; 7 at 5 minutes</NAME>
<GROUP_LABEL_1>ECG</GROUP_LABEL_1>
<GROUP_LABEL_2>No ECG</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ECG analysis</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.781242235383387" CI_END="1.2398419826366487" CI_START="0.7255422869201766" DF="4" EFFECT_SIZE="0.948450202963677" ESTIMABLE="YES" EVENTS_1="103" EVENTS_2="108" I2="0.0" ID="CMP-001.06.01" LOG_CI_END="0.0933663380316342" LOG_CI_START="-0.13933727042005056" LOG_EFFECT_SIZE="-0.022985466194208173" MODIFIED="2011-01-26 17:38:59 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4364203187600234" P_Z="0.6986128125798339" STUDIES="5" TAU2="0.0" TOTAL_1="7678" TOTAL_2="7624" WEIGHT="100.00000000000001" Z="0.3871937028244636">
<NAME>ST analysis</NAME>
<DICH_DATA CI_END="1.5338591609129124" CI_START="0.5304650219625137" EFFECT_SIZE="0.902030284126354" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="28" LOG_CI_END="0.18578548448493756" LOG_CI_START="-0.2753432475203878" LOG_EFFECT_SIZE="-0.0447788815177251" ORDER="52809" O_E="0.0" SE="0.27086929980396524" STUDY_ID="STD-Amer_x002d_Wahlin-2001" TOTAL_1="2519" TOTAL_2="2447" VAR="0.0733701775762904" WEIGHT="26.222062404807737"/>
<DICH_DATA CI_END="2.931932873719428" CI_START="0.4413966101414585" EFFECT_SIZE="1.1376050420168067" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.46715402295853" LOG_CI_START="-0.35517100647683797" LOG_EFFECT_SIZE="0.055991508240846" ORDER="52811" O_E="0.0" SE="0.48303779286488024" STUDY_ID="STD-Ojala-2006" TOTAL_1="714" TOTAL_2="722" VAR="0.23332550933577495" WEIGHT="7.343804751870227"/>
<DICH_DATA CI_END="3.081939752600381" CI_START="0.32609943521703083" EFFECT_SIZE="1.0025062656641603" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.4888241446455586" LOG_CI_START="-0.4866499533631304" LOG_EFFECT_SIZE="0.0010870956412141369" MODIFIED="2008-11-10 16:59:02 +0000" MODIFIED_BY="[Empty name]" ORDER="44" O_E="0.0" SE="0.5729983138449649" STUDY_ID="STD-Vayssiere-2007" TOTAL_1="399" TOTAL_2="400" VAR="0.3283270676691729" WEIGHT="5.531777833966004"/>
<DICH_DATA CI_END="1.9445824627709027" CI_START="0.7919530670727579" EFFECT_SIZE="1.2409746353440563" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="34" LOG_CI_END="0.28882636474601475" LOG_CI_START="-0.10130055491968784" LOG_EFFECT_SIZE="0.09376290491316344" MODIFIED="2011-01-26 17:38:59 +0000" MODIFIED_BY="[Empty name]" ORDER="50" O_E="0.0" SE="0.2291624837710314" STUDY_ID="STD-Westerhuis-2010" TOTAL_1="2827" TOTAL_2="2840" VAR="0.05251544396810823" WEIGHT="31.314023696252445"/>
<DICH_DATA CI_END="1.0829691110355864" CI_START="0.35833490113030425" EFFECT_SIZE="0.6229491386382281" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="32" LOG_CI_END="0.034616069646458" LOG_CI_START="-0.44571089032640937" LOG_EFFECT_SIZE="-0.2055474103399757" ORDER="52810" O_E="0.0" SE="0.2821464339448605" STUDY_ID="STD-Westgate-1993" TOTAL_1="1219" TOTAL_2="1215" VAR="0.07960661018780152" WEIGHT="29.588331313103588"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.6235698217650094" CI_START="0.10986733797974817" DF="0" EFFECT_SIZE="0.4223473621813871" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" I2="0.0" ID="CMP-001.06.02" LOG_CI_END="0.2104709702365659" LOG_CI_START="-0.9591313980537206" LOG_EFFECT_SIZE="-0.3743302139085774" NO="2" P_CHI2="1.0" P_Z="0.20963510056866597" STUDIES="1" TAU2="0.0" TOTAL_1="482" TOTAL_2="475" WEIGHT="100.0" Z="1.254569514352922">
<NAME>PR analysis</NAME>
<DICH_DATA CI_END="1.6235698217650094" CI_START="0.10986733797974817" EFFECT_SIZE="0.4223473621813871" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.2104709702365659" LOG_CI_START="-0.9591313980537206" LOG_EFFECT_SIZE="-0.3743302139085774" ORDER="52812" O_E="0.0" SE="0.6870302207588113" STUDY_ID="STD-Strachan-2000" TOTAL_1="482" TOTAL_2="475" VAR="0.47201052423590095" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.663876115418927" CI_END="1.864561401951099" CI_START="0.8467160726395342" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2564848218165225" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="44" I2="24.92143352974672" I2_Q="12.52561703680677" ID="CMP-001.07" LOG_CI_END="0.27057668970293464" LOG_CI_START="-0.07226219623117043" LOG_EFFECT_SIZE="0.0991572467358821" METHOD="MH" MODIFIED="2015-12-21 12:52:02 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.2639653593849115" P_Q="0.2849789299060501" P_Z="0.25690473821338455" Q="1.1431918307109088" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="6728" TOTAL_2="6773" WEIGHT="200.0" Z="1.1337373931721066">
<NAME>Neonatal intubation</NAME>
<GROUP_LABEL_1>ECG</GROUP_LABEL_1>
<GROUP_LABEL_2>No ECG</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ECG analysis</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.5272800067691281" CI_END="2.107813375655535" CI_START="0.8941002075738238" DF="1" EFFECT_SIZE="1.3728060229691943" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="36" I2="34.52412160390669" ID="CMP-001.07.01" LOG_CI_END="0.323832156108376" LOG_CI_START="-0.0486138042941219" LOG_EFFECT_SIZE="0.13760917590712707" MODIFIED="2015-09-24 11:00:19 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2165215556010054" P_Z="0.14752973533467653" STUDIES="2" TAU2="0.0" TOTAL_1="6246" TOTAL_2="6298" WEIGHT="100.00000000000001" Z="1.4483122782630515">
<NAME>ST analysis</NAME>
<DICH_DATA CI_END="2.539046045414835" CI_START="0.9682369738744511" EFFECT_SIZE="1.5679280147826786" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="27" LOG_CI_END="0.4046705768438893" LOG_CI_START="-0.01401833706070284" LOG_EFFECT_SIZE="0.1953261198915932" MODIFIED="2015-09-24 11:00:19 +0100" MODIFIED_BY="[Empty name]" ORDER="51" O_E="0.0" SE="0.24593994057110674" STUDY_ID="STD-Belfort-2015" TOTAL_1="5532" TOTAL_2="5576" VAR="0.06048645436811951" WEIGHT="75.03031832541595"/>
<DICH_DATA CI_END="2.1003940319208705" CI_START="0.29450200586366526" EFFECT_SIZE="0.7864923747276689" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.32230077560839404" LOG_CI_START="-0.5309117428716008" LOG_EFFECT_SIZE="-0.1043054836316033" ORDER="52821" O_E="0.0" SE="0.5011812568252306" STUDY_ID="STD-Ojala-2006" TOTAL_1="714" TOTAL_2="722" VAR="0.2511826521929178" WEIGHT="24.969681674584066"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.113991663144143" CI_START="0.2584118345616331" DF="0" EFFECT_SIZE="0.7391078838174274" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" I2="0.0" ID="CMP-001.07.02" LOG_CI_END="0.32510327026675545" LOG_CI_START="-0.5876876007113213" LOG_EFFECT_SIZE="-0.13129216522228293" NO="2" P_CHI2="1.0" P_Z="0.5728721069398877" STUDIES="1" TAU2="0.0" TOTAL_1="482" TOTAL_2="475" WEIGHT="100.0" Z="0.5638266627540304">
<NAME>PR analysis</NAME>
<DICH_DATA CI_END="2.113991663144143" CI_START="0.2584118345616331" EFFECT_SIZE="0.7391078838174274" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.32510327026675545" LOG_CI_START="-0.5876876007113213" LOG_EFFECT_SIZE="-0.13129216522228293" ORDER="52822" O_E="0.0" SE="0.5361778760002052" STUDY_ID="STD-Strachan-2000" TOTAL_1="482" TOTAL_2="475" VAR="0.2874867147120914" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.026104956480398" CI_END="1.0368516382118385" CI_START="0.8885784415782619" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9598562459192227" ESTIMABLE="YES" EVENTS_1="1135" EVENTS_2="1183" I2="0.4331978395484994" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="0.01571661818701477" LOG_CI_START="-0.051304227688863856" LOG_EFFECT_SIZE="-0.017793804750924534" METHOD="MH" MODIFIED="2015-12-21 12:52:02 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.42027228240548953" P_Q="0.4335187487796933" P_Z="0.2980020821831515" Q="0.613378536635701" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="13692" TOTAL_2="13675" WEIGHT="200.0" Z="1.040727433501453">
<NAME>Admission neonatal special care unit</NAME>
<GROUP_LABEL_1>ECG</GROUP_LABEL_1>
<GROUP_LABEL_2>No ECG</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ECG analysis</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.420939443821356" CI_END="1.0425765931969522" CI_START="0.8920646316122642" DF="5" EFFECT_SIZE="0.9643887725071298" ESTIMABLE="YES" EVENTS_1="1113" EVENTS_2="1155" I2="7.765064490826068" ID="CMP-001.08.01" LOG_CI_END="0.01810797039004726" LOG_CI_START="-0.04960367910402358" LOG_EFFECT_SIZE="-0.015747854356988156" MODIFIED="2015-09-24 11:02:04 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.36669313436405815" P_Z="0.3619442192012763" STUDIES="6" TAU2="0.0" TOTAL_1="13210" TOTAL_2="13200" WEIGHT="100.00000000000001" Z="0.9116666808178013">
<NAME>ST analysis</NAME>
<DICH_DATA CI_END="1.110198746429686" CI_START="0.7410152240358888" EFFECT_SIZE="0.9070138768563338" ESTIMABLE="YES" EVENTS_1="169" EVENTS_2="181" LOG_CI_END="0.04540073261665126" LOG_CI_START="-0.13017286942032089" LOG_EFFECT_SIZE="-0.04238606840183483" ORDER="52823" O_E="0.0" SE="0.10313280293986424" STUDY_ID="STD-Amer_x002d_Wahlin-2001" TOTAL_1="2519" TOTAL_2="2447" VAR="0.01063637504223287" WEIGHT="15.903029471408699"/>
<DICH_DATA CI_END="1.2046886830222436" CI_START="0.9468241494548904" EFFECT_SIZE="1.0680020307379887" ESTIMABLE="YES" EVENTS_1="498" EVENTS_2="470" LOG_CI_END="0.08087483055093396" LOG_CI_START="-0.02373067359757368" LOG_EFFECT_SIZE="0.028572078476680137" MODIFIED="2015-09-24 11:02:04 +0100" MODIFIED_BY="[Empty name]" ORDER="52" O_E="0.0" SE="0.06144579094242998" STUDY_ID="STD-Belfort-2015" TOTAL_1="5532" TOTAL_2="5576" VAR="0.00377558522454081" WEIGHT="40.54375743583102"/>
<DICH_DATA CI_END="1.7242721952381603" CI_START="0.5930238316325936" EFFECT_SIZE="1.011204481792717" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="26" LOG_CI_END="0.23660582503790692" LOG_CI_START="-0.2269278534509775" LOG_EFFECT_SIZE="0.004838985793464709" ORDER="52825" O_E="0.0" SE="0.27228197727308495" STUDY_ID="STD-Ojala-2006" TOTAL_1="714" TOTAL_2="722" VAR="0.07413747514774076" WEIGHT="2.2392209900313254"/>
<DICH_DATA CI_END="2.7152085998502056" CI_START="0.25704460831382286" EFFECT_SIZE="0.835421888053467" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4338032005118942" LOG_CI_START="-0.5899915013247156" LOG_EFFECT_SIZE="-0.0780941504064107" MODIFIED="2008-11-10 17:02:49 +0000" MODIFIED_BY="[Empty name]" ORDER="47" O_E="0.0" SE="0.6013820757243321" STUDY_ID="STD-Vayssiere-2007" TOTAL_1="399" TOTAL_2="400" VAR="0.3616604010025063" WEIGHT="0.5189878651369756"/>
<DICH_DATA CI_END="1.0100948358625987" CI_START="0.7854151029943519" EFFECT_SIZE="0.8906984560125194" ESTIMABLE="YES" EVENTS_1="391" EVENTS_2="441" LOG_CI_END="0.004362150771041575" LOG_CI_START="-0.1049007517999488" LOG_EFFECT_SIZE="-0.05026930051445362" MODIFIED="2011-01-26 17:40:27 +0000" MODIFIED_BY="[Empty name]" ORDER="51" O_E="0.0" SE="0.06418156983029034" STUDY_ID="STD-Westerhuis-2010" TOTAL_1="2827" TOTAL_2="2840" VAR="0.0041192739058804355" WEIGHT="38.105794580318616"/>
<DICH_DATA CI_END="1.3069809814819704" CI_START="0.4555908281633708" EFFECT_SIZE="0.7716531265712244" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="31" LOG_CI_END="0.11626926799559484" LOG_CI_START="-0.34142502760903" LOG_EFFECT_SIZE="-0.11257787980671759" ORDER="52824" O_E="0.0" SE="0.2688518948614594" STUDY_ID="STD-Westgate-1993" TOTAL_1="1219" TOTAL_2="1215" VAR="0.0722813413705972" WEIGHT="2.6892096572733664"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3338070422835289" CI_START="0.4494997304519864" DF="0" EFFECT_SIZE="0.774303497332543" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="28" I2="0.0" ID="CMP-001.08.02" LOG_CI_END="0.12509300609268265" LOG_CI_START="-0.3472705643606746" LOG_EFFECT_SIZE="-0.11108877913399598" NO="2" P_CHI2="1.0" P_Z="0.35659396172723246" STUDIES="1" TAU2="0.0" TOTAL_1="482" TOTAL_2="475" WEIGHT="100.0" Z="0.921874673697582">
<NAME>PR analysis</NAME>
<DICH_DATA CI_END="1.3338070422835289" CI_START="0.4494997304519864" EFFECT_SIZE="0.774303497332543" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="28" LOG_CI_END="0.12509300609268265" LOG_CI_START="-0.3472705643606746" LOG_EFFECT_SIZE="-0.11108877913399598" ORDER="52826" O_E="0.0" SE="0.27746869952168646" STUDY_ID="STD-Strachan-2000" TOTAL_1="482" TOTAL_2="475" VAR="0.07698887921425593" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.8826313772125565" CI_END="4.366297823208262" CI_START="0.733235536535728" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="1.789280505419676" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="0.6401133554144894" LOG_CI_START="-0.13475649495453487" LOG_EFFECT_SIZE="0.2526784302299773" METHOD="MH" MODIFIED="2015-12-21 12:52:02 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.8651352233690937" P_Q="0.7461646695506423" P_Z="0.20115956145167657" Q="0.10478214562445182" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="13711" TOTAL_2="13692" WEIGHT="200.0" Z="1.2782549809752408">
<NAME>Perinatal death</NAME>
<GROUP_LABEL_1>ECG</GROUP_LABEL_1>
<GROUP_LABEL_2>No ECG</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ECG analysis</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.7717953786179568" CI_END="4.3293284890796135" CI_START="0.6718897203621622" DF="4" EFFECT_SIZE="1.7055296267973896" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" I2="0.0" ID="CMP-001.09.01" LOG_CI_END="0.6364205392856173" LOG_CI_START="-0.17270200338733072" LOG_EFFECT_SIZE="0.23185926794914324" MODIFIED="2015-09-24 11:04:39 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7776383514813415" P_Z="0.2613183723655258" STUDIES="6" TAU2="0.0" TOTAL_1="13229" TOTAL_2="13217" WEIGHT="100.0" Z="1.1232805680111388">
<NAME>ST analysis</NAME>
<DICH_DATA CI_END="8.712815213374151" CI_START="0.24368882755541793" EFFECT_SIZE="1.4571258435887258" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9401585033531449" LOG_CI_START="-0.6131643815344301" LOG_EFFECT_SIZE="0.16349706090935742" ORDER="52802" O_E="0.0" SE="0.9124295516552494" STUDY_ID="STD-Amer_x002d_Wahlin-2001" TOTAL_1="2519" TOTAL_2="2447" VAR="0.8325276867337995" WEIGHT="28.90557886124817"/>
<DICH_DATA CI_END="29.061096140060123" CI_START="0.3146383859586803" EFFECT_SIZE="3.0238611713665944" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4633119911939882" LOG_CI_START="-0.5021882944493032" LOG_EFFECT_SIZE="0.4805618483723425" MODIFIED="2015-09-24 11:04:39 +0100" MODIFIED_BY="[Empty name]" ORDER="53" O_E="0.0" SE="1.1545445971701969" STUDY_ID="STD-Belfort-2015" TOTAL_1="5532" TOTAL_2="5576" VAR="1.332973226854892" WEIGHT="14.189808138472957"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="52804" O_E="0.0" SE="0.0" STUDY_ID="STD-Ojala-2006" TOTAL_1="733" TOTAL_2="739" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.178380458070496" CI_START="0.013653969961854334" EFFECT_SIZE="0.33416666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9126673100575547" LOG_CI_START="-1.86474105691244" LOG_EFFECT_SIZE="-0.4760368734274425" MODIFIED="2008-11-10 16:56:43 +0000" MODIFIED_BY="[Empty name]" ORDER="42" O_E="0.0" SE="1.6314634231513228" STUDY_ID="STD-Vayssiere-2007" TOTAL_1="399" TOTAL_2="400" VAR="2.6616729010806317" WEIGHT="21.3426802183493"/>
<DICH_DATA CI_END="9.011389966264103" CI_START="0.2519856428608808" EFFECT_SIZE="1.5068977714892111" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9547917841112086" LOG_CI_START="-0.5986242028848099" LOG_EFFECT_SIZE="0.17808379061319932" MODIFIED="2011-01-26 17:42:06 +0000" MODIFIED_BY="[Empty name]" ORDER="52" O_E="0.0" SE="0.9124842402946121" STUDY_ID="STD-Westerhuis-2010" TOTAL_1="2827" TOTAL_2="2840" VAR="0.8326274887860353" WEIGHT="28.427116839477705"/>
<DICH_DATA CI_END="103.69750893870071" CI_START="0.23950753082615675" EFFECT_SIZE="4.983606557377049" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.015768323725872" LOG_CI_START="-0.6206808265298985" LOG_EFFECT_SIZE="0.6975437485979867" ORDER="52803" O_E="0.0" SE="1.5486632814940113" STUDY_ID="STD-Westgate-1993" TOTAL_1="1219" TOTAL_2="1215" VAR="2.3983579594477997" WEIGHT="7.134815942451869"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="72.3935406774075" CI_START="0.12074310376531619" DF="0" EFFECT_SIZE="2.9565217391304346" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-001.09.02" LOG_CI_END="1.859699817947087" LOG_CI_START="-0.9181376645698" LOG_EFFECT_SIZE="0.4707810766886434" NO="2" P_CHI2="1.0" P_Z="0.5064728776953991" STUDIES="1" TAU2="0.0" TOTAL_1="482" TOTAL_2="475" WEIGHT="100.0" Z="0.6643397684134468">
<NAME>PR analysis</NAME>
<DICH_DATA CI_END="72.3935406774075" CI_START="0.12074310376531619" EFFECT_SIZE="2.9565217391304346" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.859699817947087" LOG_CI_START="-0.9181376645698" LOG_EFFECT_SIZE="0.4707810766886434" ORDER="52805" O_E="0.0" SE="1.6317154877477233" STUDY_ID="STD-Strachan-2000" TOTAL_1="482" TOTAL_2="475" VAR="2.662495432955791" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2015-11-30 16:39:07 +0000" MODIFIED_BY="Heather Maxwell">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2015-11-30 16:39:07 +0000" MODIFIED_BY="Heather Maxwell" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAAEACAMAAABVk4iuAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2015-11-30 16:39:07 +0000" MODIFIED_BY="Heather Maxwell" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAVEAAAInCAIAAACuh/1UAAAbWUlEQVR42u3dv24kxdfGcUtIiMDB
BnsFXIMjZBFBxD2xoQMkCPcuEJeAWH7hshEZAmzEOiDwQsafVb9jLCG/9kxP90xX9TlVn0cjZMbe
43ZNfeucqq6u5+SEiHrTQER9CPNEmCcizBMR5okI80SEeSLCPBFhnogwT0SYp2C9x25OzFMn/WbK
m4R5aqHTHPxdwjwRYZ6yJXy9CPPUF/CqeswT5gnzhHnCPDXQewCPeSLCPBFhnhrpPbbfYp466Tr3
v9CLME99MQ97zBPmCfPULvZ6EeaJCPNEhHlKWtIzPsQ8EWGeiDBPrfUehT3mqZ9Z/fg7hHnCPGGe
msBeL8I89TKNN6XHPBFhnogwT0SYJyLMExHmKVDvcTYW5qmTrrPrC8I8YZ4wT5gnzFPS+bxehHki
wjwRYZ7amNKbzGOe+gIe9pgnzBPmqdXeY90e80SEeSLCPLVV2+tImKfGu45GwDxhvkgFobUxT81i
v7VD6qWYp4iT+eM70ngEHRXzRIR5amvWoH9inkKX94sDr6rHPEVMxctiiXnMUwLmFyQT85invph/
MI3XPzFPEbHXizBPRJgnmtUvbb/FPPVAZrk7AoR5WoDMossEpX8X5ilKzsQ85jHf+Gcw5c0+sdc/
Md9RhRz8o7HShnkyWhHmqdFqttCBGUOZJ/MJ83GBT5RF9RzMU0fMy8aYp+7yfLUBRQ/BfLOfhMJ+
4ISHeeoNe8xjnrqbz3O2x3yPCGkEU3rMt18ke5KMMN8j80OeZTypGPPUC/NW2jBPi2Gf9F6djoR5
6mKQwjzmqbPeU2A+b90e841ny1x3p0pfmw6JeQo6TmEe89RpVV90Hx5h3ty48QrfPjzM91It50p0
ug3mqS/mYY95WoyfjBtvF5/PK+wx38U0Xkcf7PbBPGFeF8U8xSpSlsUS85in0Nm4xLOApjmYp76Y
J8wT5gnzjc6Nc23FW/aCeVdhvrucSYR5zGsN7YN52Ldb29uhhPlOJ/M9n4GpQ2KeVOCEeQqG/eLn
4RlKMN9XeZ90PrLIxasgMK9O1hp29WJeL490tYtfeQkyt4bqsP9jXmbrgp8K4xTmqX0y1cmYJ5lt
4RFwKHZHwHyeKNxotfgTe54FxHyU/l3HHyLdyfmYxzx10csxj/ke596d9/LSjrfdAo/5cJ27xNL9
4sx7+g3ztHye7zmz2ZWIeVL1nJT7FZin9ZNblk+k2vn2i0cucecf8xSlmk20UlCtna3bY75Z5stl
tjqeFomuGfN0VDaO38uT3kW39xbzvVQQiRymZGPMU1+ZDfOY76u218UHDjmYV4GnIFNHwjytyXzp
zKbbYJ76yvMlrrD+PjzMUzsz2KTYP45cdIef+TwZTY7KycHJxDzmO5o1JOrlpXcid74kgflYSThR
zsxVm3jmH/OdpvoSZ864V4d56rSCKB1TR8V8m4gOaU+zWbAdprxJmG+h/M5+iFXY+XzGNQjMYz7B
3KHnzJmlNsE85ntf5uhtDQLzKsMex1Y9TUPIbF2MU6XPFA9e1WNeZls4cop9ROVuN2SZnWE+4pQ+
17nRC/6uCnsKnAKM+XDAp8tsFfJ8558g5jEfIrMN1h23tUb8YcunJUsE7pfGKczLEl2NgInmI5in
uDmzUHnS7bpjhdoE8x3ltBK7xHK5zWRhPpH7JeZjVfXjb3bCfMZ1R+v2FK4v5srzees1zFPj83nA
l17dwDz1NU4tNZrwrsI8LT9r6LBOxjyFY7L0elgu5gs9I5CrgsA8LbNMEPx5FWddYz4BQmEzW/3W
iD8fwTyt3xdltjbGKcxjPlBmS3Q+d31nbvN5aq3sLL33NldtgnlaoA4v0R1T7DbNW/WkGMEx3135
kGK/faJ6Kt26CeYxv1h3j5+QrWhiPm55nyJyzcmOHoJ52bij1tDOmMd8y7WJ3QqYx/wy3X0ofJRN
xnNy1PbUbM5M8bzKSE7OeM18aWnNCqL0qXXx9+GVxnJra/ClpXaYzzhDrr86iHkadvUMLg67hqqk
jreYJ4oyH6k5tmKe5mUJzC8+HwmehDHfzQdQoLbPe0e6GvODPTkUJ89rkKI3Gnp+/hfz1FEFMST0
2MN8RyAtHnnxrpno/rxKDfOhZ7Cd78MrkY1Le4Emwh7zEZkfcp5sEfyaS3uBms9T48wPOT1ePZaP
+YjYd35mhjtqmKdO+2UK4HlX0TJz40wZwwlW8jyFwt4d6VU+Pnme5iVMJ1Incshx1jVFzD+lz8xI
dM11TuBR21NrzKeuTSqcDoh5Wq2aTbQGXpn5PrHHfPsVeAMLHD1XPZjH/DJpp9CG01xNbR8etZbn
S+8wLzQ3JsyrZvuqk4eKewo63MmPeYo4Ny4x0yl6F92eHOoO+6TP/KeoIDDfRW3v3Nsh1V0MzFOU
/JN6BCzROLxDMN84807OH6kg3KujprDnuN7GrAHzvUzmO3z2YxecTt3CPCEz7jXHH20x32MREZxM
6/aY74vMIcnDXpgfaWq1Pa3PT6JrHgrcq6uwDy/LiinmG2e+NPbpFsD5bWG+/TzvXl3GWTfmO5rP
p3sQvQQ/GZ+EyXJuJ+Yp4tz4/heeLMY8hcg/SVcHXTPmQ2dO/LhmzLeM/UgHitkXiz6jdv9XZBy4
zedpXp28VCme1MeGMI/5cPlHt0naGpgPXRmmsGFO2s5DgTsCmKeOBqkUHcneJ8x3CqcK3JkZmDfP
7KICT+oXhHmKwny6J/OHMiuaRf2CME9RsK/g65zu+Xn352n9anZwTg5hPnIqdmZG6ZxpRRPzmF/m
spM+/yvPU2vM6+iaAvPR5/NFDZUSJWRbhjFPHY1T6UaTRJZBmKfFyMzoGF0oeOQ7DpiPiFCW053L
EVV6T0G1ERDztAI/icapvPN5zFP7zJerI0ofyF/Tfx7zNK/HBM+ZGWfdhPleKoj4567DHvO0PPPD
ck+PVvZ+U09hvvHa3vMqudZNnIdHgXpMxnOjMY95zEe/7FwOUyUu2xmY1Dj2NXNm/Pm8MzApUI+p
5leXgnnCfC/lQ6KTLTCPeQrKfLXCJ/IaROk7l5hvv7wfnCeZcA1CnqeWK/B0mc0aBOZV4JkScvC7
gKWfWcY85uXMHK2htqfa+adczsx7God9eJjvq0hO1MszVuD24RHmO6rAzecpUI+pM2tIMU4R5rtL
R8HHqQorBbyrMA/7fv/2FM8CYl6/XyC5ad4Kqxvm87QOls14wmAe87Qy89VO10xR8mCe2se+5t7B
zp8FxHwXtX3RlXDM62waNFY2TncKfelzpjrMxpjvrvz2oaRrZ7U96YsdtbM1PIpCZtLRJF1rYJ5k
th7HqRRTM8xjXs5cfiiJPJnCfLhOM+TZB14os1nRxHxH2TjX2VjlMpt1R8xjnvqt1DCP+RAVOCUd
tTEftFQ2N86VjTFP4fLPgszn3VdfjkzMU8sVRLkpa7XHchM5dmK+iwlh3kX7yJEHa6WYjwl8lr6Y
tMJPeh7RgvkA85in0Ngv3jcwj/mIM9iMz9hkmY9gPhY/uYAvx8/ikdO5x2KeluzuHTKfesa0bD7A
vElmR8wT5jHf13x+yLMrHvPUXUGbYm6ccXaG+e4m85zwhsL78IaSO/nN51uGU5skYj5RZN1L+d31
2NrhaIL59plXPjQwa7j/UartYT8vbNGdZ/EfszG2Yr7x+Xzpc6NHEl2oyHn34WFekg+U57e+U+JM
jiyHzJX47BYfpzBvPo/55ZtanqeVsa85mpQ76zrRKdqRscJ80Mm8DyXXTKdonl+2Y+hejfdvo0m1
1Y0sd14wT0uWJyki55pPYb4XflJktnRLGyXu2FWop5YdpzDfbM1Z+o503lPu85ZR7tVhfmV+YF/h
Eyw1lKBOj1kkCwWPXGKlIN0OP8w3Pp8fPKWrMMF8n72859OgrBRgvl/mh+X2xpaoZiuvgZcbUCJf
MOYjzoo5tNVs8EJkhsUe8xHLzsU/4/sftkauEznsiibmg/bFBIculKntk+4pGJyZQQ0zX7M2KRq5
69kN6qIlz/j8JPWuynjnctlTtDGvgugociIyH//tzr2l9fnJ6F1Vup2ddU2Hl53d8pNxDoV5OjYb
U9KZTlFXLOfkYL6X2iTLzhn36igE9qk3sSZa3Ug2UkMuWsLMuLqeourJuLphHx4FqmZNdtLtHcQ8
5iPWJp75x3yP5X3P1WwdhBLV9phvtiM62SL1TGfZfXjOwOyI+SH8c3VDzjMzkt6fV9tjfs0s0dgc
Kv6ozdOiC+x9IkZttT3FTZU9nxtds4JQ25Pafplm6bQFEBKhFxYd3Slpqy4+QmE+UC+8v2pdtAMt
O04V2pAzFLBzL2cX/WA5JvKNBszHYr5opyzRERe3TC0Uuej0uEJrLPgnYD5cni+EegVr5PjMl9tT
gHlan/lyCwSp83y1TxDzJM9j3nyeat1Rq/DcW/D780Xb+UGo4I9IYb7HIUY76AM6ARHmiQjzRIR5
IsI8EWG+9yYmqivMr8m8yCLHiYx5zIuMedJjRMY86TEiY570RZExT/qiyJjH/PgP3Px9c3F5cf7q
/Mm3T06+Pjl9cXr28uzZT89+++u3sJHfvr158+bi+vr86urJzz+fXF6evn59dnPz7O3buJEztnOJ
yJhfmfnnvz5/+r+nm4/z8WvzMX/xyxcBI//xx/Orq6cbIB+/NqD+/nvEyBnbuVBkzK/J/GbA3vqJ
3n9tfiZU5E3K3crk/dfmZ0JFztjO5SJjfjXmN6P43g/17rVrRK8feZOH92J599qVk+tHztjO5SLP
Y77aesP0g9y2fusA86BdJ8xPfPOAi9zM03aVbVsLues/r1ePvJlp3y+8v/nm5MMPT9577/b1yScn
3333sBT/55/1I2ds53KR5zFf1CN56xnvxzN/8G+f9eaw7/CZrd+6uLyY+KGOVHGVI795c3Gfvfff
v/2rv/rq5Msvb7/44INJdXjlyBnbuVzkY5l/bMAwJStuHTtGfuAxWntNIHa5BU75Sw9gfu9ouPVb
56/Ot3x+d9r2uZ69PFs98vX1+dZi+4cfbmO/++7D91+/Xj9yxnYuF3kB5rfSvpeQKQX5AdHGv5hY
8B+W5w9g/u7Wy/TP9fTF6eqR726ePXh9//3JRx/dxv7884ffurxcP3LGdi4XeQbzcwvdiW9OrCMO
JnMKq3v/zELMb/9E7+vRR7t65K2p+OOPb0N++un29bbVI2ds53KR5zH/+LncKYSM/Kut7++d2E+5
hhTMN5Pn33nnNvCPP27B8sg8v0hkeX61PL/3UvYyf0ApMYv5vUsMyzLf0nx+1+v4+fzxkc3nD2F+
132pZWv7YZ9lx97J+THMT//VSzHfwLr93etO0/fPVI5s3b4q8yMr7Qcwf5/2ZZnfdaKQ+/Pjd9HH
yTzm/vyCkd2fP3zdnhbZfXBf9uHViWwfHuajMD/Yb18rsv32mI/C/N2Ivn2d9t+y7bOrzwJG/vfp
tye7n36LGDljOxeKjPmVmR92PyO9dZ4WJPKup9y3zrSDRM7YziUiY3595kUWuWZkzGNeZMyTHiMy
5kmPERnzpC+KjHnSF0XGPOaJ+NLK8yKLLM9jXmSRMY95kUXGPOZFFhnzmBdZZMxjXmSRMR+R+YxO
rH/f3FxeXLw6P//2yZOvT05enJ6+PDv76dmzv36LG5kvLeZDMJ/RifXX58//9/Tp1nMcNqD+8kXE
yHxpMR+C+Ywnw2xS7t4jmzY/Eyqyc3IwH4L5jCfAbfLwxONYd+Xk+pGdhxed+Yn7Bx//YbNMuHb9
0r1vDvtOzp34GzM6sW5m2rsK762l+J/X60d27m0O5qdPeA6znR4fOEbe3DWyzD0sfMjpxHp5cTEn
8PY6vHJk59vnZn7cl3aXK9bjH5tyFv10C9pZxch/yujE+ur8fBaZL8/Wj8zHJjHzx9hXLOVLu+t/
x4eSZpxY726eTX+9OF0/Mr+6xPP5I5mf2BZ7vx6mOdvtbf2MTqyP+9vTPYHXj8yXNneeH3e5XYv5
KQuEE/N8cCdWeV6eX622n5LwhwK+tAsyn9GJ1XzefD7TfH4ulqVr+4xOrNbtrdtXnc8Poy63081w
R8JO8aUdvz8/PflndGJ1f979eTqkcvlP9uHViWwfHuajMD/Yb18rsv32mI/C/JDTiXWTk3ettG/e
v/osYmS+tJiPwvyQ04l111PuW2faQSLzpcV8FOZFFrlmZMxjXmTMkx4jMuZJjxEZ86Qviox50hdF
xjzmifjSyvMiiyzPY15kkTGPeZFFxjzmRRYZ85gXWWTMY15kkTEfkfmMfqnlvHQzuvTypaUZn2tG
v9RyXroZXXr50tKM1s94ykq5s30ynhrknBya0foZT1Mrd4ZfxtMBnYdXnJytR9YuskAy3Zd2loPt
yGVkPDW1nJduRpde597WS5XHWNBOD37km3svI+Pp6OW8dDO69DrfvmptfPCx9tM9ZA9jfvrQk9EF
pZyXbkaXXj42KzM/0eVmOM6XdtygelZtn9HtrJyXbkaXXn516+f5ud+dPoM40ui6GVfTcl66GV16
+dIGqu0nfndB5g+YzzeT5xfx0s3o0ivPp6/tpzhPLsh8S/P54710M7r0ms+vs26/Fe9x19pjfGmt
2xfy0s3o0mvdvgb24/fn//vuSG0/jLrKTvGldX++hJduRpde9+ejlP2JLtI+vDqR7cNrh/ksl22/
/eqR7bdvJ883MDZl9Est56Wb0aWXLy3Nrkcy+qWW89LN6NLLl5YqzUFEFhnzmBdZZMxjXmSRMY95
kTFPmBcZ86THiIx5OqD1ifjSyvMiiyzPY15kkTGPeZFFxjzmRRYZ85gXWWTMY15kkTEfkXnusff1
983N5cXFq/Pzb588+frk5MXp6cuzs5+ePfvrtx4db0tcM+ZXZp577H39+vz5/54+3XpCxGYI+OWL
vhxvC10z5tdk3mk297VJ5nsPg9r8TKhrzvgJYn415p1a9yDDTzzodVe2b+mkvXLXXJX5XWfLRlj/
aMmXNqN77GYOv6uk31rk/3ndsuNtuWuuyvyuM6ojMN+YL21G99jLi4s5jbG9wm/G8bbcNa/P/P30
+Pho+l3pdGuQ8ay710ayPvPcY+/r1fn5LOZfnrXseFvumtdkfis5c42oxi1rhjk2kvWZ5x57X3e3
5aa/Xpy27Hhb7ppjzeenDApTavLpAE8s8gsxzz32vh4z8nRPY7TseFvumtdctx/Pz8M+k9m9iI4b
1EZgnnvsink+uONtuWuOtYY3i7fFsRwa8qXN6B5bfz4f2fG23DUnYH6vyex4wGOwbGbdPoV7bLV1
+xSOt+WuOcp8fqtd7Nb3R+7tzzKoHbmwBnxpM7rHVrs/n8Lxttw1rzmf70r24U2JbB9enWvG/JrM
D/bb/3/Zb1/nmjG/JvMD99hH2X7XGv7m/avP+nK8LXTNmF+Z+YF77KO5/dbn57fO4YNcc65PEPPr
My+yyDUjYx7zImOe9BiRMU96jMiYJ31RZMyTvigy5jFPxJdWnhdZZHke8yKLjHnMiywy5jEvssiY
x7zIImMe8yKLjPmIzPNLrXPNGSPzpW2QeX6pda45Y2S+tA0y7/yWOtecMbJzchpk3jltda45Y+R8
5+GNHx0dcP3jmCNu92545Je64jVnjJzSl7YO8yWutohNFb/U9a45Y+SsvrR7jaXG0ZruNjv+3fGY
I5d9APOzzrfnl1rnmjNGzupLO5GZKe8Mk51qh0N9bI5nfqIN3n/il1rnmjNGzupLO9c0dtyg9gDb
2SmON9Nrk8WZ55da55ozRk7sSztiSvU4CR9gGvW4bh/J7ROfK67GPL9UeX5oz5d2pFYfyfMHpPe9
/3bKH3iwL+30+cKUOVuffqnm83XauTjzw6gd7US3yWPm8wdMNKoxzy/Vuv3QpC/tLhPYvXXyUuv2
4zHHK/9ZN+3nMs8v1f35oWdf2rY3AtqHt+4124cXjvnmd/7ab7/6NdtvHy7Pd8v8wC+11jVnjMyX
tk3mB36pta45Y2S+tG0yL7LINSNjHvMiY570GJExT3qMyJgnfVFkzJO+KDLmMU/El1aeF1lkeR7z
IouMecyLLDLmMS+yyJjHvMgiYx7zIouM+YjMc2IVuWZkzK/MPCdWkStHxvyazDsZRuT6kTG/GvNO
gBO5fuSjmB8/+3VuzOk/X+gnJx5xO+w+zHeWX52TXkWuH3lJ5vceX70KyQf/IcM+j829/3zvBTvR
XeT6kQsyP/eU+PH/fRD/v//OdcJYypd2EeY5t4hcP/IC8/m9PpOFTGbn/qKlfGn3/u905jm0iVw/
8mLMT0/4U8A4zDRqOvNzi/xCzHNiFbl+5ErMT7SFmmUye9hIsfcvrcm8/CNy+3l+Yi09y2T2mIJi
+m2IEsybZ4qccj4/THZ0HQqbzB4w2z/sr1iKeevJIudbt59CyzDHZHbvuv3Eu2hza/tZvrTuz4vc
7/15OnJDgf1hIifbh0dHMj/YBy6y/fa9MT9wYhW5emTMr8z8wIlV5LqRMb8+8yKLXDMy5jEvMuZJ
jxEZ86THiIx50hdFxjzpiyJjHvNEfGnleZFFlucxL7LImMe8yCJjHvMii4x5zIssMuYxL7LImI/I
fEa/1Ldvb968ubi+Pr+6evLzzyeXl6evX5/d3Dx7+/Y3rRG8NTC/MvMZ/VL/+OP51dXTTed+/Np0
+t9//0JrRG4NzK/JfMZTVjbpa2v/vv/a/IzWCNsamF+N+YynqW1y2t4ufvfald+0xrrXXJb5tYxr
D/snE0+zneVgO3IZGU9N3cxa7xex33xz8uGHJ++9d/v65JOT7757WNb+88+11gjVGlWZr2lce8A/
meg2O+vs/fE3M56O/ubNxf1+/P77t4321VcnX355+8UHH0yqabXGite8JvOLGNeOx9nrdTsyHi2L
dzMuKNfX51sL1x9+uI397rsP33/9+kxrhGqNGvP5osa1ew3tZvnSVmY+o9vZ3Y2oB6/vvz/56KPb
2J9//vBbl5enWiNUa9RjvoJx7fhPHsP8LjOsrYXJ9ClGRlfTrWnt449vQ3766fa1K60RqjWiMH+A
ce2ubLzLzXbKc8W71vCGfQ5Znef5d965Dfzjj1u6eId5PnhrhMvzU2YHQzH/+fE2WvzNlmawu159
zucjt0al+/PljGv3Vt115vPdrtvfve40fS+K1mh53X4K88MRxrXDBF/aKev27s8fdkd6vJf3dn8+
RWtUYr6oUly5nWdao5d9eOUQ2pu0swxMdphrjfrXbL/9ysVIRr/Uf58ke7L7SbLPtEbk1sD8+hOQ
jH6pu54Y3zpr1RqhrhnziRcdRBYZ85gXWWTMY15kkTGPeZExT5gXGfOkx4iMeTqg9Yn40hLRqklI
QxBhnogwT0SYJyLMExHmiQjzRLQO80TUj/4Pagqv71vdOrwAAAAASUVORK5CYII=
</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2014-08-19 13:53:39 +0100" MODIFIED_BY="Leanne V Jones"/>
<EXTENSIONS/>
</COCHRANE_REVIEW>